5il2 › Citations

Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex.

Wang X, Feng J, Xue Y, Guan Z, Zhang D, Liu Z, Gong Z, Wang Q, Huang J, Tang C, Zou T, Yin P
Nature 534 575-8 (2016)
Related entries: 5il0, 5il1

Cited: 520 times
EuropePMC logo PMID: 27281194

Abstract

Chemical modifications of RNA have essential roles in a vast range of cellular processes. N(6)-methyladenosine (m(6)A) is an abundant internal modification in messenger RNA and long non-coding RNA that can be dynamically added and removed by RNA methyltransferases (MTases) and demethylases, respectively. An MTase complex comprising methyltransferase-like 3 (METTL3) and methyltransferase-like 14 (METTL14) efficiently catalyses methyl group transfer. In contrast to the well-studied DNA MTase, the exact roles of these two RNA MTases in the complex remain to be elucidated. Here we report the crystal structures of the METTL3-METTL14 heterodimer with MTase domains in the ligand-free, S-adenosyl methionine (AdoMet)-bound and S-adenosyl homocysteine (AdoHcy)-bound states, with resolutions of 1.9, 1.71 and 1.61 Å, respectively. Both METTL3 and METTL14 adopt a class I MTase fold and they interact with each other via an extensive hydrogen bonding network, generating a positively charged groove. Notably, AdoMet was observed in only the METTL3 pocket and not in METTL14. Combined with biochemical analysis, these results suggest that in the m(6)A MTase complex, METTL3 primarily functions as the catalytic core, while METTL14 serves as an RNA-binding platform, reminiscent of the target recognition domain of DNA N(6)-adenine MTase. This structural information provides an important framework for the functional investigation of m(6)A.

Reviews - 5il2 mentioned but not cited (2)

  1. A comprehensive review of m6A/m6Am RNA methyltransferase structures. Oerum S, Meynier V, Catala M, Tisné C. Nucleic Acids Res 49 7239-7255 (2021)
  2. Structural Insights into N6-methyladenosine (m6A) Modification in the Transcriptome. Huang J, Yin P. Genomics Proteomics Bioinformatics 16 85-98 (2018)

Articles - 5il2 mentioned but not cited (6)

  1. Self-association of a highly charged arginine-rich cell-penetrating peptide. Tesei G, Vazdar M, Jensen MR, Cragnell C, Mason PE, Heyda J, Skepö M, Jungwirth P, Lund M. Proc Natl Acad Sci U S A 114 11428-11433 (2017)
  2. Structural insights into the RNA methyltransferase domain of METTL16. Ruszkowska A, Ruszkowski M, Dauter Z, Brown JA. Sci Rep 8 5311 (2018)
  3. Effect of Humantenine on mRNA m6A Modification and Expression in Human Colon Cancer Cell Line HCT116. Wu Y, Chen X, Bao W, Hong X, Li C, Lu J, Zhang D, Zhu A. Genes (Basel) 13 781 (2022)
  4. research-article A cryptic pocket in METTL3-METTL14 regulates m6A conversion and sensing. Gupta Y, Qi S. Res Sq rs.3.rs-3150186 (2023)
  5. Chemical biology and medicinal chemistry of RNA methyltransferases. Fischer TR, Meidner L, Schwickert M, Weber M, Zimmermann RA, Kersten C, Schirmeister T, Helm M. Nucleic Acids Res 50 4216-4245 (2022)
  6. Structure-Based Design of Inhibitors of the m6A-RNA Writer Enzyme METTL3. Bedi RK, Huang D, Li Y, Caflisch A. ACS Bio Med Chem Au 3 359-370 (2023)


Reviews citing this publication (242)

  1. Dynamic RNA Modifications in Gene Expression Regulation. Roundtree IA, Evans ME, Pan T, He C. Cell 169 1187-1200 (2017)
  2. Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. Shi H, Wei J, He C. Mol Cell 74 640-650 (2019)
  3. The m6A epitranscriptome: transcriptome plasticity in brain development and function. Livneh I, Moshitch-Moshkovitz S, Amariglio N, Rechavi G, Dominissini D. Nat Rev Neurosci 21 36-51 (2020)
  4. The functions of N6-methyladenosine modification in lncRNAs. He RZ, Jiang J, Luo DX. Genes Dis 7 598-605 (2020)
  5. Rethinking m6A Readers, Writers, and Erasers. Meyer KD, Jaffrey SR. Annu. Rev. Cell Dev. Biol. 33 319-342 (2017)
  6. m6A in mRNA: An Ancient Mechanism for Fine-Tuning Gene Expression. Roignant JY, Soller M. Trends Genet. 33 380-390 (2017)
  7. Reading m6A in the Transcriptome: m6A-Binding Proteins. Patil DP, Pickering BF, Jaffrey SR. Trends Cell Biol. 28 113-127 (2018)
  8. The chemical diversity of RNA modifications. Ontiveros RJ, Stoute J, Liu KF. Biochem J 476 1227-1245 (2019)
  9. m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Huang H, Weng H, Chen J. Cancer Cell 37 270-288 (2020)
  10. The RNA Modification N6-methyladenosine and Its Implications in Human Disease. Batista PJ. Genomics Proteomics Bioinformatics 15 154-163 (2017)
  11. Roles of RNA methylation by means of N6-methyladenosine (m6A) in human cancers. Wang S, Sun C, Li J, Zhang E, Ma Z, Xu W, Li H, Qiu M, Xu Y, Xia W, Xu L, Yin R. Cancer Lett. 408 112-120 (2017)
  12. Regulation of Gene Expression by N6-methyladenosine in Cancer. Liu J, Harada BT, He C. Trends Cell Biol 29 487-499 (2019)
  13. Functions of RNA N6-methyladenosine modification in cancer progression. Chen B, Li Y, Song R, Xue C, Xu F. Mol Biol Rep 46 2567-2575 (2019)
  14. The Potential Roles of RNA N6-Methyladenosine in Urological Tumors. Li Y, Ge YZ, Xu L, Xu Z, Dou Q, Jia R. Front Cell Dev Biol 8 579919 (2020)
  15. Emerging roles of N6-methyladenosine (m6A) modification in breast cancer. Wang Y, Zhang Y, Du Y, Zhou M, Hu Y, Zhang S. Cell Biosci 10 136 (2020)
  16. RNA methyltransferase METTL16: Targets and function. Satterwhite ER, Mansfield KD. Wiley Interdiscip Rev RNA 13 e1681 (2022)
  17. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential. Huang W, Chen TQ, Fang K, Zeng ZC, Ye H, Chen YQ. J Hematol Oncol 14 117 (2021)
  18. RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications. Gu C, Shi X, Dai C, Shen F, Rocco G, Chen J, Huang Z, Chen C, He C, Huang T, Chen C. Innovation (Camb) 1 100066 (2020)
  19. mRNA methylation in cell senescence. Casella G, Tsitsipatis D, Abdelmohsen K, Gorospe M. Wiley Interdiscip Rev RNA 10 e1547 (2019)
  20. Regulatory Role of N6 -methyladenosine (m6 A) Methylation in RNA Processing and Human Diseases. Wei W, Ji X, Guo X, Ji S. J. Cell. Biochem. 118 2534-2543 (2017)
  21. Viral Epitranscriptomics. Kennedy EM, Courtney DG, Tsai K, Cullen BR. J. Virol. 91 (2017)
  22. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions. Imam H, Kim GW, Siddiqui A. Front Cell Infect Microbiol 10 584283 (2020)
  23. Functions of RNA N6-methyladenosine modification in cancer progression. Chen B, Li Y, Song R, Xue C, Xu F. Mol Biol Rep 46 1383-1391 (2019)
  24. Readers, writers and erasers of N6-methylated adenosine modification. Wu B, Li L, Huang Y, Ma J, Min J. Curr. Opin. Struct. Biol. 47 67-76 (2017)
  25. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology. Fang X, Li M, Yu T, Liu G, Wang J. Genes Dis 7 585-597 (2020)
  26. The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs. Jacob R, Zander S, Gutschner T. Int J Mol Sci 18 (2017)
  27. Hidden codes in mRNA: Control of gene expression by m6A. Murakami S, Jaffrey SR. Mol Cell 82 2236-2251 (2022)
  28. The crosstalk between m6A RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling. Zhao Y, Chen Y, Jin M, Wang J. Theranostics 11 4549-4566 (2021)
  29. Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate. Xu Y, Liu J, Chen WJ, Ye QQ, Chen WT, Li CL, Wu HT. Front Cell Dev Biol 8 561703 (2020)
  30. Epitranscriptomic systems regulate the translation of reactive oxygen species detoxifying and disease linked selenoproteins. Leonardi A, Evke S, Lee M, Melendez JA, Begley TJ. Free Radic Biol Med 143 573-593 (2019)
  31. YTH Domain: A Family of N6-methyladenosine (m6A) Readers. Liao S, Sun H, Xu C. Genomics Proteomics Bioinformatics 16 99-107 (2018)
  32. RNA epitranscriptomics: Regulation of infection of RNA and DNA viruses by N6 -methyladenosine (m6 A). Tan B, Gao SJ. Rev. Med. Virol. 28 e1983 (2018)
  33. RNA-modifying enzymes and their function in a chromatin context. Tzelepis K, Rausch O, Kouzarides T. Nat Struct Mol Biol 26 858-862 (2019)
  34. Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escape. Li W, Hao Y, Zhang X, Xu S, Pang D. Mol Cancer 21 176 (2022)
  35. The potential role of RNA N6-methyladenosine in Cancer progression. Wang T, Kong S, Tao M, Ju S. Mol Cancer 19 88 (2020)
  36. m6A-binding proteins: the emerging crucial performers in epigenetics. Zhao Y, Shi Y, Shen H, Xie W. J Hematol Oncol 13 35 (2020)
  37. Chromatin and transcriptional regulation by reversible RNA methylation. Wei J, He C. Curr Opin Cell Biol 70 109-115 (2021)
  38. Epigenetic regulations in mammalian spermatogenesis: RNA-m6A modification and beyond. Gui Y, Yuan S. Cell Mol Life Sci 78 4893-4905 (2021)
  39. From A to m6A: The Emerging Viral Epitranscriptome. Baquero-Perez B, Geers D, Díez J. Viruses 13 1049 (2021)
  40. Human m6A writers: Two subunits, 2 roles. Wang X, Huang J, Zou T, Yin P. RNA Biol 14 300-304 (2017)
  41. RNA methylation in mammalian development and cancer. Song P, Tayier S, Cai Z, Jia G. Cell Biol Toxicol 37 811-831 (2021)
  42. RNA-Binding Proteins as Regulators of Migration, Invasion and Metastasis in Oral Squamous Cell Carcinoma. Weiße J, Rosemann J, Krauspe V, Kappler M, Eckert AW, Haemmerle M, Gutschner T. Int J Mol Sci 21 E6835 (2020)
  43. Roles of RNA Methylation on Tumor Immunity and Clinical Implications. Zhang M, Song J, Yuan W, Zhang W, Sun Z. Front Immunol 12 641507 (2021)
  44. m6A in the Signal Transduction Network. Jang KH, Heras CR, Lee G. Mol Cells 45 435-443 (2022)
  45. Long Non-Coding RNA Epigenetics. Kazimierczyk M, Wrzesinski J. Int J Mol Sci 22 6166 (2021)
  46. Mapping N6 -Methyladenosine (m6 A) in RNA: Established Methods, Remaining Challenges, and Emerging Approaches. Hartstock K, Rentmeister A. Chemistry 25 3455-3464 (2019)
  47. Metabolic Control of m6A RNA Modification. Kim J, Lee G. Metabolites 11 80 (2021)
  48. Novel insights into m6A modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance. Jia J, Wu S, Jia Z, Wang C, Ju C, Sheng J, He F, Zhou M, He J. Int J Biol Sci 18 4432-4451 (2022)
  49. RNA m6A methylation regulators in ovarian cancer. Guo J, Zheng J, Zhang H, Tong J. Cancer Cell Int 21 609 (2021)
  50. Regulation of RNA N6-methyladenosine modification and its emerging roles in skeletal muscle development. Li J, Pei Y, Zhou R, Tang Z, Yang Y. Int J Biol Sci 17 1682-1692 (2021)
  51. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases. Zhang B, Jiang H, Dong Z, Sun A, Ge J. Genes Dis 8 746-758 (2021)
  52. The emerging role of mRNA methylation in normal and pathological behavior. Engel M, Chen A. Genes Brain Behav. 17 e12428 (2018)
  53. m6 A-mediated regulation of crop development and stress responses. Zhou L, Gao G, Tang R, Wang W, Wang Y, Tian S, Qin G. Plant Biotechnol J 20 1447-1455 (2022)
  54. A mark of disease: how mRNA modifications shape genetic and acquired pathologies. Destefanis E, Avşar G, Groza P, Romitelli A, Torrini S, Pir P, Conticello SG, Aguilo F, Dassi E. RNA 27 367-389 (2021)
  55. Dual effects of N6-methyladenosine on cancer progression and immunotherapy. Li H, Wu H, Wang Q, Ning S, Xu S, Pang D. Mol Ther Nucleic Acids 24 25-39 (2021)
  56. Interactions between m6A modification and miRNAs in malignant tumors. Han X, Guo J, Fan Z. Cell Death Dis 12 598 (2021)
  57. RNA Epigenetics: Fine-Tuning Chromatin Plasticity and Transcriptional Regulation, and the Implications in Human Diseases. Willbanks A, Wood S, Cheng JX. Genes (Basel) 12 627 (2021)
  58. RNA epigenetics and cardiovascular diseases. Dorn LE, Tual-Chalot S, Stellos K, Accornero F. J Mol Cell Cardiol 129 272-280 (2019)
  59. RNA methylation in nuclear pre-mRNA processing. Covelo-Molares H, Bartosovic M, Vanacova S. Wiley Interdiscip Rev RNA 9 e1489 (2018)
  60. RNA-modifying proteins as anticancer drug targets. Boriack-Sjodin PA, Ribich S, Copeland RA. Nat Rev Drug Discov 17 435-453 (2018)
  61. Role of N6-Methyladenosine (m6A) Methylation Regulators in Hepatocellular Carcinoma. Qu N, Bo X, Li B, Ma L, Wang F, Zheng Q, Xiao X, Huang F, Shi Y, Zhang X. Front Oncol 11 755206 (2021)
  62. The Role of RNA Methyltransferase METTL3 in Normal and Malignant Hematopoiesis. Wu X, Ye W, Gong Y. Front Oncol 12 873903 (2022)
  63. The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer. Sun CY, Cao D, Du BB, Chen CW, Liu D. Int J Biol Sci 18 2744-2758 (2022)
  64. Adenosine methylation as a molecular imprint defining the fate of RNA. Knuckles P, Bühler M. FEBS Lett. 592 2845-2859 (2018)
  65. Insight into m6A methylation from occurrence to functions. Ru W, Zhang X, Yue B, Qi A, Shen X, Huang Y, Lan X, Lei C, Chen H. Open Biol 10 200091 (2020)
  66. N 6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development. Niu Y, Wan A, Lin Z, Lu X, Wan G. Acta Pharm Sin B 8 833-843 (2018)
  67. N6 -methyladenosine Steers RNA Metabolism and Regulation in Cancer. Dong S, Wu Y, Liu Y, Weng H, Huang H. Cancer Commun (Lond) 41 538-559 (2021)
  68. RNA N6 -methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential. Zhang Z, Zhang C, Luo Y, Zhang G, Wu P, Sun N, He J. Clin Transl Med 11 e525 (2021)
  69. RNA modifications in hematopoietic malignancies: a new research frontier. Qing Y, Su R, Chen J. Blood 138 637-648 (2021)
  70. RNA tales - how embryos read and discard messages from mom. Despic V, Neugebauer KM. J. Cell. Sci. 131 (2018)
  71. Role of RNA N6-Methyladenosine Modification in Male Infertility and Genital System Tumors. Liu S, Lao Y, Wang Y, Li R, Fang X, Wang Y, Gao X, Dong Z. Front Cell Dev Biol 9 676364 (2021)
  72. Small changes, big implications: The impact of m6A RNA methylation on gene expression in pluripotency and development. Heck AM, Wilusz CJ. Biochim Biophys Acta Gene Regul Mech 1862 194402 (2019)
  73. The Biological Function, Mechanism, and Clinical Significance of m6A RNA Modifications in Head and Neck Carcinoma: A Systematic Review. Jing FY, Zhou LM, Ning YJ, Wang XJ, Zhu YM. Front Cell Dev Biol 9 683254 (2021)
  74. The Proteins of mRNA Modification: Writers, Readers, and Erasers. Flamand MN, Tegowski M, Meyer KD. Annu Rev Biochem 92 145-173 (2023)
  75. m6A Modification in Non-Coding RNA: The Role in Cancer Drug Resistance. Chen C, Guo Y, Guo Y, Wu X, Si C, Xu Y, Kang Q, Sun Z. Front Oncol 11 746789 (2021)
  76. m6A RNA Modification Determines Cell Fate by Regulating mRNA Degradation. Guo M, Liu X, Zheng X, Huang Y, Chen X. Cell Reprogram 19 225-231 (2017)
  77. Crosstalk Between Histone and m6A Modifications and Emerging Roles of m6A RNA Methylation. Xu Z, Xie T, Sui X, Xu Y, Ji L, Zhang Y, Zhang A, Chen J. Front Genet 13 908289 (2022)
  78. Elucidating the Functions of Non-Coding RNAs from the Perspective of RNA Modifications. Garikipati VNS, Uchida S. Noncoding RNA 7 31 (2021)
  79. Emerging Role of m6 A Methylome in Brain Development: Implications for Neurological Disorders and Potential Treatment. Sokpor G, Xie Y, Nguyen HP, Tuoc T. Front Cell Dev Biol 9 656849 (2021)
  80. Epigenetic Regulation of Endothelial Cell Function by Nucleic Acid Methylation in Cardiac Homeostasis and Disease. Russell-Hallinan A, Watson CJ, O'Dwyer D, Grieve DJ, O'Neill KM. Cardiovasc Drugs Ther 35 1025-1044 (2021)
  81. Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology. Yang X, Liu M, Li M, Zhang S, Hiju H, Sun J, Mao Z, Zheng M, Feng B. Mol Cancer 19 64 (2020)
  82. Insights into N6-methyladenosine and programmed cell death in cancer. Liu L, Li H, Hu D, Wang Y, Shao W, Zhong J, Yang S, Liu J, Zhang J. Mol Cancer 21 32 (2022)
  83. Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer. Chen Y, Lin Y, Shu Y, He J, Gao W. Mol Cancer 19 94 (2020)
  84. Link Between m6A Modification and Cancers. Liu ZX, Li LM, Sun HL, Liu SM. Front Bioeng Biotechnol 6 89 (2018)
  85. Lysine-Targeted Inhibitors and Chemoproteomic Probes. Cuesta A, Taunton J. Annu Rev Biochem 88 365-381 (2019)
  86. N6-methyladenosine as a Novel Regulator of Brain Physiology and Diseases. Han B, Yao HH. Curr Med Sci 40 401-406 (2020)
  87. RNA methylation in hematological malignancies and its interactions with other epigenetic modifications. Yao L, Yin H, Hong M, Wang Y, Yu T, Teng Y, Li T, Wu Q. Leukemia 35 1243-1257 (2021)
  88. Regulatory role of RNA N6-methyladenosine modifications during skeletal muscle development. Yu B, Liu J, Zhang J, Mu T, Feng X, Ma R, Gu Y. Front Cell Dev Biol 10 929183 (2022)
  89. Research progress of m6A methylation in prostate cancer. Zhang SY, Zeng Y. Asian J Androl 25 166-170 (2023)
  90. The Emerging Field of Epitranscriptomics in Neurodevelopmental and Neuronal Disorders. Angelova MT, Dimitrova DG, Dinges N, Lence T, Worpenberg L, Carré C, Roignant JY. Front Bioeng Biotechnol 6 46 (2018)
  91. The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer. Cheng Y, Wang M, Zhou J, Dong H, Wang S, Xu H. Genes (Basel) 12 440 (2021)
  92. The Interaction Between N6-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers. Yao L, Man CF, He R, He L, Huang JB, Xiang SY, Dai Z, Wang XY, Fan Y. Front Oncol 11 784127 (2021)
  93. The METTL3-m6A Epitranscriptome: Dynamic Regulator of Epithelial Development, Differentiation, and Cancer. Maldonado López A, Capell BC. Genes (Basel) 12 1019 (2021)
  94. The RNA Epitranscriptome of DNA Viruses. Tan B, Gao SJ. J. Virol. 92 (2018)
  95. The Role of Dynamic m6 A RNA Methylation in Photobiology. Robinson M, Shah P, Cui YH, He YY. Photochem. Photobiol. 95 95-104 (2019)
  96. The Status and Prospects of Epigenetics in the Treatment of Lymphoma. Liu J, Li JN, Wu H, Liu P. Front Oncol 12 874645 (2022)
  97. The importance of N6-methyladenosine modification in tumor immunity and immunotherapy. Zhang Z, Liu F, Chen W, Liao Z, Zhang W, Zhang B, Liang H, Chu L, Zhang Z. Exp Hematol Oncol 11 30 (2022)
  98. The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer. Luo L, Zhen Y, Peng D, Wei C, Zhang X, Liu X, Han L, Zhang Z. Cell Death Discov 8 325 (2022)
  99. m6A Methylation in Cardiovascular Diseases: From Mechanisms to Therapeutic Potential. Li L, Xu N, Liu J, Chen Z, Liu X, Wang J. Front Genet 13 908976 (2022)
  100. m6A Modification: A Double-Edged Sword in Tumor Development. Gao R, Ye M, Liu B, Wei M, Ma D, Dong K. Front Oncol 11 679367 (2021)
  101. m6A: Widespread regulatory control in virus replication. Manners O, Baquero-Perez B, Whitehouse A. Biochim Biophys Acta Gene Regul Mech 1862 370-381 (2019)
  102. Aberrant Regulation of mRNA m⁶A Modification in Cancer Development. Luo J, Liu H, Luan S, He C, Li Z. Int J Mol Sci 19 (2018)
  103. Advances in mRNA 5-methylcytosine modifications: Detection, effectors, biological functions, and clinical relevance. Guo G, Pan K, Fang S, Ye L, Tong X, Wang Z, Xue X, Zhang H. Mol Ther Nucleic Acids 26 575-593 (2021)
  104. Beta class amino methyltransferases from bacteria to humans: evolution and structural consequences. Woodcock CB, Horton JR, Zhang X, Blumenthal RM, Cheng X. Nucleic Acids Res 48 10034-10044 (2020)
  105. Biological roles of the RNA m6A modification and its implications in cancer. Hong J, Xu K, Lee JH. Exp Mol Med 54 1822-1832 (2022)
  106. Crosstalk between m6A modification and alternative splicing during cancer progression. Zhu ZM, Huo FC, Zhang J, Shan HJ, Pei DS. Clin Transl Med 13 e1460 (2023)
  107. Dawn of Epitranscriptomic Medicine. Gatsiou A, Stellos K. Circ Genom Precis Med 11 e001927 (2018)
  108. Dynamic and reversible RNA N6 -methyladenosine methylation. Duan HC, Wang Y, Jia G. Wiley Interdiscip Rev RNA 10 e1507 (2019)
  109. Emerging role of m6A methylation modification in ovarian cancer. Chang LL, Xu XQ, Liu XL, Guo QQ, Fan YN, He BX, Zhang WZ. Cancer Cell Int 21 663 (2021)
  110. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer. Liang Z, Kidwell RL, Deng H, Xie Q. Cancer Biol Med 17 9-19 (2020)
  111. Epitranscriptomic Signatures in lncRNAs and Their Possible Roles in Cancer. Dinescu S, Ignat S, Lazar AD, Constantin C, Neagu M, Costache M. Genes (Basel) 10 (2019)
  112. Functions of RNA N6-methyladenosine modification in acute myeloid leukemia. Zheng X, Gong Y. Biomark Res 9 36 (2021)
  113. Insights into roles of METTL14 in tumors. Liu X, Du Y, Huang Z, Qin H, Chen J, Zhao Y. Cell Prolif 55 e13168 (2022)
  114. METTL3 plays multiple functions in biological processes. Liu S, Zhuo L, Wang J, Zhang Q, Li Q, Li G, Yan L, Jin T, Pan T, Sui X, Lv Q, Xie T. Am J Cancer Res 10 1631-1646 (2020)
  115. Multifaceted Functions and Novel Insight Into the Regulatory Role of RNA N6-Methyladenosine Modification in Musculoskeletal Disorders. Zhang W, He L, Liu Z, Ren X, Qi L, Wan L, Wang W, Tu C, Li Z. Front Cell Dev Biol 8 870 (2020)
  116. Multifaceted Roles of the N6-Methyladenosine RNA Methyltransferase METTL3 in Cancer and Immune Microenvironment. Hu C, Liu J, Li Y, Jiang W, Ji D, Liu W, Ma T. Biomolecules 12 1042 (2022)
  117. N6-Methyladenosine Modification and Its Regulation of Respiratory Viruses. Feng Q, Zhao H, Xu L, Xie Z. Front Cell Dev Biol 9 699997 (2021)
  118. N6-Methyladenosine Role in Acute Myeloid Leukaemia. Ianniello Z, Fatica A. Int J Mol Sci 19 (2018)
  119. N6-Methyladenosine in RNA and DNA: An Epitranscriptomic and Epigenetic Player Implicated in Determination of Stem Cell Fate. Ji P, Wang X, Xie N, Li Y. Stem Cells Int 2018 3256524 (2018)
  120. N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target. Quan C, Belaydi O, Hu J, Li H, Yu A, Liu P, Yi Z, Qiu D, Ren W, Ma H, Gong G, Ou Z, Chen M, Sun Y, Chen J, Zu X. Front Immunol 12 697026 (2021)
  121. Novel insight into the functions of N6‑methyladenosine modified lncRNAs in cancers (Review). He Y, Du X, Chen M, Han L, Sun J. Int J Oncol 61 152 (2022)
  122. RNA N6-methyladenosine modification in female reproductive biology and pathophysiology. Huang E, Chen L. Cell Commun Signal 21 53 (2023)
  123. RNA m6A modification and its function in diseases. Tong J, Flavell RA, Li HB. Front Med 12 481-489 (2018)
  124. RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis. Ma W, Wu T. Am J Physiol Cell Physiol 323 C1190-C1205 (2022)
  125. RNA modifications: importance in immune cell biology and related diseases. Cui L, Ma R, Cai J, Guo C, Chen Z, Yao L, Wang Y, Fan R, Wang X, Shi Y. Signal Transduct Target Ther 7 334 (2022)
  126. RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer. Li W, Deng X, Chen J. Semin Cancer Biol 86 664-677 (2022)
  127. Regulatory Role of N6-methyladenosine (m6A) Modification in Osteosarcoma. Zhang Y, Wang Y, Ying L, Tao S, Shi M, Lin P, Wang Y, Han B. Front Oncol 11 683768 (2021)
  128. Roles and implications of mRNA N6 -methyladenosine in cancer. Zeng L, Huang X, Zhang J, Lin D, Zheng J. Cancer Commun (Lond) 43 729-748 (2023)
  129. Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy. Zhou X, Li C, Chen T, Li W, Wang X, Yang Q. Mol Cancer 22 36 (2023)
  130. The Progression of N6-methyladenosine Study and Its Role in Neuropsychiatric Disorders. Lei C, Wang Q. Int J Mol Sci 23 5922 (2022)
  131. The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis. Fu J, Cui X, Zhang X, Cheng M, Li X, Guo Z, Cui X. Front Genet 12 733871 (2021)
  132. The m6A-epitranscriptomic signature in neurobiology: from neurodevelopment to brain plasticity. Widagdo J, Anggono V. J. Neurochem. 147 137-152 (2018)
  133. The role of RNA methyltransferase METTL3 in gynecologic cancers: Results and mechanisms. Zhang Y, Zhang N. Front Pharmacol 14 1156629 (2023)
  134. The role of RNA modification in hepatocellular carcinoma. Feng Q, Wang D, Xue T, Lin C, Gao Y, Sun L, Jin Y, Liu D. Front Pharmacol 13 984453 (2022)
  135. m6 A RNA methylation: from mechanisms to therapeutic potential. He PC, He C. EMBO J 40 e105977 (2021)
  136. m6A Modification in Mammalian Nervous System Development, Functions, Disorders, and Injuries. Yu J, She Y, Ji SJ. Front Cell Dev Biol 9 679662 (2021)
  137. m6A-SAC-seq for quantitative whole transcriptome m6A profiling. Ge R, Ye C, Peng Y, Dai Q, Zhao Y, Liu S, Wang P, Hu L, He C. Nat Protoc 18 626-657 (2023)
  138. Advances in brain epitranscriptomics research and translational opportunities. Zhang F, Ignatova VV, Ming GL, Song H. Mol Psychiatry (2023)
  139. Advances in targeting RNA modifications for anticancer therapy. Pomaville MM, He C. Trends Cancer 9 528-542 (2023)
  140. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review. Sahafnejad Z, Ramazi S, Allahverdi A. Genes (Basel) 14 873 (2023)
  141. Analysis approaches for the identification and prediction of N6-methyladenosine sites. Yang Y, Liu Z, Lu J, Sun Y, Fu Y, Pan M, Xie X, Ge Q. Epigenetics 18 2158284 (2023)
  142. Cross-Talk between Oxidative Stress and m6A RNA Methylation in Cancer. Yang B, Chen Q. Oxid Med Cell Longev 2021 6545728 (2021)
  143. Current Insights into m6A RNA Methylation and Its Emerging Role in Plant Circadian Clock. Chuong NN, Doan PPT, Wang L, Kim JH, Kim J. Plants (Basel) 12 624 (2023)
  144. Do RNA modifications contribute to modulation of immune responses in allergic diseases? Kudrin P, Rebane A. Front Allergy 4 1277244 (2023)
  145. Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response. Yan Y, Peng J, Liang Q, Ren X, Cai Y, Peng B, Chen X, Wang X, Yi Q, Xu Z. Genes Dis 10 135-150 (2023)
  146. Dynamic regulation and functions of mRNA m6A modification. Wang S, Lv W, Li T, Zhang S, Wang H, Li X, Wang L, Ma D, Zang Y, Shen J, Xu Y, Wei W. Cancer Cell Int 22 48 (2022)
  147. Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases. Xu Z, Lv B, Qin Y, Zhang B. Cells 11 1101 (2022)
  148. Emerging Roles of Long Noncoding RNAs in Breast Cancer Epigenetics and Epitranscriptomics. Wanowska E, Samorowska K, Szcześniak MW. Front Cell Dev Biol 10 922351 (2022)
  149. Emerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications. Song B, Zeng Y, Cao Y, Zhang J, Xu C, Pan Y, Zhao X, Liu J. Front Immunol 14 1221609 (2023)
  150. Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers. Xu Y, Yu X, Guo W, He Y. Front Immunol 14 1129298 (2023)
  151. Epigenetic Methylations on N6-Adenine and N6-Adenosine with the same Input but Different Output. Li Z, Zhao P, Xia Q. Int J Mol Sci 20 (2019)
  152. Epigenetic modification of m6A regulator proteins in cancer. Wang Y, Wang Y, Patel H, Chen J, Wang J, Chen ZS, Wang H. Mol Cancer 22 102 (2023)
  153. Epigenetics in Neurodevelopment: Emerging Role of Circular RNA. Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Wu M. Front Cell Neurosci 13 327 (2019)
  154. Epitranscriptomic RNA Methylation in Plant Development and Abiotic Stress Responses. Hu J, Manduzio S, Kang H. Front Plant Sci 10 500 (2019)
  155. Epitranscriptomic modifications in mesenchymal stem cell differentiation: advances, mechanistic insights, and beyond. Zheng J, Lu Y, Lin Y, Si S, Guo B, Zhao X, Cui L. Cell Death Differ (2023)
  156. Epitranscriptomics in metabolic disease. Matsumura Y, Wei FY, Sakai J. Nat Metab 5 370-384 (2023)
  157. Epitranscriptomics of cardiovascular diseases (Review). Leptidis S, Papakonstantinou E, Diakou KI, Pierouli K, Mitsis T, Dragoumani K, Bacopoulou F, Sanoudou D, Chrousos GP, Vlachakis D. Int J Mol Med 49 9 (2022)
  158. Epitranscriptomics: A New Regulatory Mechanism of Brain Development and Function. Noack F, Calegari F. Front Neurosci 12 85 (2018)
  159. Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy. He J, Liu F, Zhang Z. Biomark Res 11 40 (2023)
  160. Functions, mechanisms, and therapeutic implications of METTL14 in human cancer. Guan Q, Lin H, Miao L, Guo H, Chen Y, Zhuo Z, He J. J Hematol Oncol 15 13 (2022)
  161. Implications of m6A methylation and microbiota interaction in non-small cell lung cancer: From basics to therapeutics. Qiu FS, He JQ, Zhong YS, Guo MY, Yu CH. Front Cell Infect Microbiol 12 972655 (2022)
  162. Interaction between N6-methyladenosine and autophagy in the regulation of bone and tissue degeneration. Wen X, Wang J, Wang Q, Liu P, Zhao H. Front Bioeng Biotechnol 10 978283 (2022)
  163. METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey. Fiorentino F, Menna M, Rotili D, Valente S, Mai A. J Med Chem 66 1654-1677 (2023)
  164. Mechanisms of RNA N6-Methyladenosine in Hepatocellular Carcinoma: From the Perspectives of Etiology. Lu J, Qian J, Yin S, Zhou L, Zheng S, Zhang W. Front Oncol 10 1105 (2020)
  165. Methyladenosine Modification in RNAs: Classification and Roles in Gastrointestinal Cancers. Li Q, He W, Wan G. Front Oncol 10 586789 (2020)
  166. Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer. Qu X, Zhang Y, Sang X, Ren D, Zhao H, Wong STC. Cancers (Basel) 14 3195 (2022)
  167. Methylation multiplicity and its clinical values in cancer. Dai X, Ren T, Zhang Y, Nan N. Expert Rev Mol Med 23 e2 (2021)
  168. Methyltransferase-like proteins in cancer biology and potential therapeutic targeting. Qi YN, Liu Z, Hong LL, Li P, Ling ZQ. J Hematol Oncol 16 89 (2023)
  169. Multiple Functions and Mechanisms Underlying the Role of METTL3 in Human Cancers. Zheng W, Dong X, Zhao Y, Wang S, Jiang H, Zhang M, Zheng X, Gu M. Front Oncol 9 1403 (2019)
  170. N6-Methyladenosine (m6A): A Promising New Molecular Target in Acute Myeloid Leukemia. Ianniello Z, Paiardini A, Fatica A. Front Oncol 9 251 (2019)
  171. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy. Guo L, Yang H, Zhou C, Shi Y, Huang L, Zhang J. Front Immunol 12 773570 (2021)
  172. N6-methyladenine RNA modification and cancer. Yang J, Chen J, Fei X, Wang X, Wang K. Oncol Lett 20 1504-1512 (2020)
  173. N6-methyladenosine (m6A) as a regulator of carcinogenesis and drug resistance by targeting epithelial-mesenchymal transition and cancer stem cells. Wang C, Danli Ma, Yu H, Zhuo Z, Ye Z. Heliyon 9 e14001 (2023)
  174. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review. Zhang Y, Xu Y, Bao Y, Luo Y, Qiu G, He M, Lu J, Xu J, Chen B, Wang Y. Epigenetics 18 2260213 (2023)
  175. N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer. Ma M, Ye T, Wang J, Zhao H, Zhang S, Li P, Zhao G. Diagnostics (Basel) 12 2996 (2022)
  176. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer. Ge Y, Liu T, Wang C, Zhang Y, Xu S, Ren Y, Feng Y, Yin L, Pu Y, Liang G. RNA Biol 18 551-561 (2021)
  177. N6-methyladenosine methylation in kidney injury. Wang Q, Fan X, Sheng Q, Yang M, Zhou P, Lu S, Gao Y, Kong Z, Shen N, Lv Z, Wang R. Clin Epigenetics 15 170 (2023)
  178. N6-methyladenosine modification: A potential regulatory mechanism in spinal cord injury. Liu D, Fan B, Li J, Sun T, Ma J, Zhou X, Feng S. Front Cell Neurosci 16 989637 (2022)
  179. N6-methyladenosine regulatory machinery in plants: composition, function and evolution. Yue H, Nie X, Yan Z, Weining S. Plant Biotechnol. J. 17 1194-1208 (2019)
  180. N6-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors. Zhan L, Zhang J, Zhu S, Liu X, Zhang J, Wang W, Fan Y, Sun S, Wei B, Cao Y. Front Cell Dev Biol 9 736298 (2021)
  181. New insights into the regulation of METTL3 and its role in tumors. Jin Q, Qu H, Quan C. Cell Commun Signal 21 334 (2023)
  182. New understandings of the genetic regulatory relationship between non-coding RNAs and m6A modification. Liu S, Xiang D. Front Genet 14 1270983 (2023)
  183. Novel Insights Into the Multifaceted Functions of RNA n6-Methyladenosine Modification in Degenerative Musculoskeletal Diseases. Li H, Xiao W, He Y, Wen Z, Cheng S, Zhang Y, Li Y. Front Cell Dev Biol 9 766020 (2021)
  184. Novel insight into RNA modifications in tumor immunity: Promising targets to prevent tumor immune escape. Kong Y, Yu J, Ge S, Fan X. Innovation (Camb) 4 100452 (2023)
  185. Novel insights into the interaction between N6-methyladenosine modification and circular RNA. Xu T, He B, Sun H, Xiong M, Nie J, Wang S, Pan Y. Mol Ther Nucleic Acids 27 824-837 (2022)
  186. One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia. Ouyang X, Gong Y. Front Immunol 13 912526 (2022)
  187. Overview of m6A and circRNAs in human cancers. Zhang L, Wang X, Zhao W, Liu J. J Cancer Res Clin Oncol (2023)
  188. RNA Modifications in Cancer Metabolism and Tumor Microenvironment. Qing Y, Wu D, Deng X, Chen J, Su R. Cancer Treat Res 190 3-24 (2023)
  189. RNA N6-Methyladenosine Modifications and Its Roles in Alzheimer's Disease. Zhang R, Zhang Y, Guo F, Li S, Cui H. Front Cell Neurosci 16 820378 (2022)
  190. RNA N6-methyladenosine: a promising molecular target in metabolic diseases. Li Y, Wang J, Huang C, Shen M, Zhan H, Xu K. Cell Biosci 10 19 (2020)
  191. RNA m6A Modification Plays a Key Role in Maintaining Stem Cell Function in Normal and Malignant Hematopoiesis. Wang P, Feng M, Han G, Yin R, Li Y, Yao S, Lu P, Wang Y, Zhang H. Front Cell Dev Biol 9 710964 (2021)
  192. RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy. Cheng C, Wu Y, Wang X, Xue Q, Huang Y, Liao F, Wang X, Duan Q, Miao C. Cell Biosci 13 126 (2023)
  193. RNA modification in cardiovascular disease: implications for therapeutic interventions. Wang C, Hou X, Guan Q, Zhou H, Zhou L, Liu L, Liu J, Li F, Li W, Liu H. Signal Transduct Target Ther 8 412 (2023)
  194. Regulation of m6A Methylome in Cancer: Mechanisms, Implications, and Therapeutic Strategies. Bhattarai PY, Kim G, Bhandari D, Shrestha P, Choi HS. Cells 13 66 (2023)
  195. Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC). Chen H, Luo W, Lu X, Zhang T. Heliyon 9 e20969 (2023)
  196. Research Progress of N6-Methyladenosine in the Cardiovascular System. Zheng N, Su J, Hu H, Wang J, Chen X. Med Sci Monit 26 e921742 (2020)
  197. Research progress of N6-methyladenosine in colorectal cancer: A review. Lin Y, Shi H, Wu L, Ge L, Ma Z. Medicine (Baltimore) 102 e36394 (2023)
  198. Reshaping the role of m6A modification in cancer transcriptome: a review. Yang G, Sun Z, Zhang N. Cancer Cell Int 20 353 (2020)
  199. Role of m6A in osteoporosis, arthritis and osteosarcoma (Review). Hu Y, Zhao X. Exp Ther Med 22 926 (2021)
  200. Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine. Xue C, Chu Q, Zheng Q, Jiang S, Bao Z, Su Y, Lu J, Li L. Signal Transduct Target Ther 7 142 (2022)
  201. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. Zeng C, Huang W, Li Y, Weng H. J Hematol Oncol 13 117 (2020)
  202. Roles of m6A modification in oral cancer (Review). Liu H, Wang Y, Xue T, Yang Z, Kan S, Hao M, Gao Y, Wang D, Liu W. Int J Oncol 62 5 (2023)
  203. Structural and functional specificity of H3K36 methylation. Lam UTF, Tan BKY, Poh JJX, Chen ES. Epigenetics Chromatin 15 17 (2022)
  204. Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy. Liu W, Liu C, Wang H, Xu L, Zhou J, Li S, Cheng Y, Zhou R, Zhao L. Comput Struct Biotechnol J 20 5150-5161 (2022)
  205. The Biogenesis and Precise Control of RNA m6A Methylation. Huang H, Weng H, Chen J. Trends Genet. 36 44-52 (2020)
  206. The Complex Roles and Therapeutic Implications of m6A Modifications in Breast Cancer. Wei M, Bai JW, Niu L, Zhang YQ, Chen HY, Zhang GJ. Front Cell Dev Biol 8 615071 (2020)
  207. The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance. Chen Z, Hu Y, Jin L, Yang F, Ding H, Zhang L, Li L, Pan T. Front Pharmacol 13 873030 (2022)
  208. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer. Hu X, Lei X, Guo J, Fu W, Sun W, Lu Q, Su W, Xu Q, Tu K. Front Oncol 12 927640 (2022)
  209. The Emerging Role of m6A Modification in Endocrine Cancer. Ji X, Wang Z, Sun W, Zhang H. Cancers (Basel) 15 1033 (2023)
  210. The Latest Research Progress of m6A Modification and Its Writers, Erasers, Readers in Infertility: A Review. Liu X, Wang H, Liu B, Qi Z, Li J, Xu B, Liu W, Xu Z, Deng Y. Front Cell Dev Biol 9 681238 (2021)
  211. The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease. Cai T, Atteh LL, Zhang X, Huang C, Bai M, Ma H, Zhang C, Fu W, Gao L, Lin Y, Meng W. Front Surg 9 819335 (2022)
  212. The RNA m6A writer WTAP in diseases: structure, roles, and mechanisms. Huang Q, Mo J, Liao Z, Chen X, Zhang B. Cell Death Dis 13 852 (2022)
  213. The Regulatory Network of METTL3 in the Nervous System: Diagnostic Biomarkers and Therapeutic Targets. Su X, Qu Y, Mu D. Biomolecules 13 664 (2023)
  214. The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. Bouyahya A, Mechchate H, Oumeslakht L, Zeouk I, Aboulaghras S, Balahbib A, Zengin G, Kamal MA, Gallo M, Montesano D, El Omari N. Biomolecules 12 367 (2022)
  215. The Role of m6A Modifications in B-Cell Development and B-Cell-Related Diseases. Wang S, Li H, Lian Z, Deng S. Int J Mol Sci 24 4721 (2023)
  216. The Role of the m6A RNA Methyltransferase METTL16 in Gene Expression and SAM Homeostasis. Mermoud JE. Genes (Basel) 13 2312 (2022)
  217. The crucial roles of m6A RNA modifications in cutaneous cancers: Implications in pathogenesis, metastasis, drug resistance, and targeted therapies. Huang C, Zhang K, Guo Y, Shen C, Liu X, Huang H, Dou X, Yu B. Genes Dis 10 2320-2330 (2023)
  218. The effects of N6-methyladenosine RNA methylation on the nervous system. Shao N, Ye T, Xuan W, Zhang M, Chen Q, Liu J, Zhou P, Song H, Cai B. Mol Cell Biochem (2023)
  219. The emerging roles of N6-methyladenosine (m6A)-modified long non-coding RNAs in human cancers. Liu J, Zhao W, Zhang L, Wang X. Cell Death Discov 8 255 (2022)
  220. The emerging roles of N6-methyladenosine RNA methylation in human cancers. Shen H, Lan Y, Zhao Y, Shi Y, Jin J, Xie W. Biomark Res 8 24 (2020)
  221. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma. Qin S, Mao Y, Chen X, Xiao J, Qin Y, Zhao L. Int J Biol Sci 17 3059-3079 (2021)
  222. The impact of RNA modifications on the biology of DNA virus infection. Rajendren S, Karijolich J. Eur J Cell Biol 101 151239 (2022)
  223. The interplay between N6-methyladenosine and precancerous liver disease: molecular functions and mechanisms. Lv Z, Ran R, Yang Y, Xiang M, Su H, Huang J. Discov Oncol 14 78 (2023)
  224. The landscape of implantation and placentation: deciphering the function of dynamic RNA methylation at the maternal-fetal interface. Wu S, Xie H, Su Y, Jia X, Mi Y, Jia Y, Ying H. Front Endocrinol (Lausanne) 14 1205408 (2023)
  225. The molecular basis of translation initiation and its regulation in eukaryotes. Brito Querido J, Díaz-López I, Ramakrishnan V. Nat Rev Mol Cell Biol (2023)
  226. The role of m6A RNA methylation in autoimmune diseases: Novel therapeutic opportunities. Shan Y, Chen W, Li Y. Genes Dis 11 252-267 (2024)
  227. The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitus. Benak D, Benakova S, Plecita-Hlavata L, Hlavackova M. Front Endocrinol (Lausanne) 14 1223583 (2023)
  228. The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities. Nombela P, Miguel-López B, Blanco S. Mol Cancer 20 18 (2021)
  229. The role of regulators of RNA m6A methylation in lung cancer. Zhang Q, Xu K. Genes Dis 10 495-504 (2023)
  230. The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer. Shi B, Liu WW, Yang K, Jiang GM, Wang H. Mol Cancer 21 163 (2022)
  231. The roles and implications of RNA m6A modification in cancer. Deng X, Qing Y, Horne D, Huang H, Chen J. Nat Rev Clin Oncol (2023)
  232. The roles and mechanisms of the m6A reader protein YTHDF1 in tumor biology and human diseases. Chen Z, Zhong X, Xia M, Zhong J. Mol Ther Nucleic Acids 26 1270-1279 (2021)
  233. The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance. Zhang Y, Gu W, Shao Y. Discov Oncol 14 141 (2023)
  234. Transcriptome programs involved in the development and structure of the cerebellum. Farini D, Marazziti D, Geloso MC, Sette C. Cell Mol Life Sci 78 6431-6451 (2021)
  235. [RNA m 6A Modification and Its Roles in Immune Function Regulation]. Zhang P, Zhao WL, Li JK, Tong JY. Sichuan Da Xue Xue Bao Yi Xue Ban 53 1118-1126 (2022)
  236. m6A Methylation Regulates Osteoblastic Differentiation and Bone Remodeling. Huang M, Xu S, Liu L, Zhang M, Guo J, Yuan Y, Xu J, Chen X, Zou J. Front Cell Dev Biol 9 783322 (2021)
  237. m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases. Ni Y, Zhang H, Chu L, Zhao Y. Antioxidants (Basel) 12 510 (2023)
  238. m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis. Jiang X, Jin Z, Yang Y, Zheng X, Chen S, Wang S, Zhang X, Qu N. Front Oncol 13 1162300 (2023)
  239. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer. Petri BJ, Klinge CM. J Mol Endocrinol 70 e220110 (2023)
  240. m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. Yue SW, Liu HL, Su HF, Luo C, Liang HF, Zhang BX, Zhang W. Mol Cancer 22 137 (2023)
  241. m6A methylation modification and immune cell infiltration: implications for targeting the catalytic subunit m6A-METTL complex in gastrointestinal cancer immunotherapy. Peng C, Xiong F, Pu X, Hu Z, Yang Y, Qiao X, Jiang Y, Han M, Wang D, Li X. Front Immunol 14 1326031 (2023)
  242. m6A reader proteins: the executive factors in modulating viral replication and host immune response. Yang D, Zhao G, Zhang HM. Front Cell Infect Microbiol 13 1151069 (2023)

Articles citing this publication (270)

  1. m6A modulates neuronal functions and sex determination in Drosophila. Lence T, Akhtar J, Bayer M, Schmid K, Spindler L, Ho CH, Kreim N, Andrade-Navarro MA, Poeck B, Helm M, Roignant JY. Nature 540 242-247 (2016)
  2. RNA m6A methylation regulates the ultraviolet-induced DNA damage response. Xiang Y, Laurent B, Hsu CH, Nachtergaele S, Lu Z, Sheng W, Xu C, Chen H, Ouyang J, Wang S, Ling D, Hsu PH, Zou L, Jambhekar A, He C, Shi Y. Nature 543 573-576 (2017)
  3. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M, Schulman J, Famulare C, Patel M, Klimek VM, Garrett-Bakelman FE, Melnick A, Carroll M, Mason CE, Jaffrey SR, Kharas MG. Nat. Med. 23 1369-1376 (2017)
  4. m6A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover. Ke S, Pandya-Jones A, Saito Y, Fak JJ, Vågbø CB, Geula S, Hanna JH, Black DL, Darnell JE, Darnell RB. Genes Dev. 31 990-1006 (2017)
  5. The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention. Pendleton KE, Chen B, Liu K, Hunter OV, Xie Y, Tu BP, Conrad NK. Cell 169 824-835.e14 (2017)
  6. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, Pilka ES, Aspris D, Leggate D, Hendrick AG, Webster NA, Andrews B, Fosbeary R, Guest P, Irigoyen N, Eleftheriou M, Gozdecka M, Dias JML, Bannister AJ, Vick B, Jeremias I, Vassiliou GS, Rausch O, Tzelepis K, Kouzarides T. Nature 593 597-601 (2021)
  7. Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine Methylation. Slobodin B, Han R, Calderone V, Vrielink JAFO, Loayza-Puch F, Elkon R, Agami R. Cell 169 326-337.e12 (2017)
  8. Structural insights into the molecular mechanism of the m(6)A writer complex. Śledź P, Jinek M. Elife 5 (2016)
  9. N6-Deoxyadenosine Methylation in Mammalian Mitochondrial DNA. Hao Z, Wu T, Cui X, Zhu P, Tan C, Dou X, Hsu KW, Lin YT, Peng PH, Zhang LS, Gao Y, Hu L, Sun HL, Zhu A, Liu J, Wu KJ, He C. Mol Cell 78 382-395.e8 (2020)
  10. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, Shi H, Skibbe J, Shen C, Hu C, Sheng Y, Wang Y, Wunderlich M, Zhang B, Dore LC, Su R, Deng X, Ferchen K, Li C, Sun M, Lu Z, Jiang X, Marcucci G, Mulloy JC, Yang J, Qian Z, Wei M, He C, Chen J. Cell Stem Cell 22 191-205.e9 (2018)
  11. UniProt: a worldwide hub of protein knowledge. UniProt Consortium. Nucleic Acids Res. 47 D506-D515 (2019)
  12. Human METTL16 is a N6-methyladenosine (m6A) methyltransferase that targets pre-mRNAs and various non-coding RNAs. Warda AS, Kretschmer J, Hackert P, Lenz C, Urlaub H, Höbartner C, Sloan KE, Bohnsack MT, Bohnsack MT. EMBO Rep. 18 2004-2014 (2017)
  13. The rRNA m6A methyltransferase METTL5 is involved in pluripotency and developmental programs. Ignatova VV, Stolz P, Kaiser S, Gustafsson TH, Lastres PR, Sanz-Moreno A, Cho YL, Amarie OV, Aguilar-Pimentel A, Klein-Rodewald T, Calzada-Wack J, Becker L, Marschall S, Kraiger M, Garrett L, Seisenberger C, Hölter SM, Borland K, Van De Logt E, Jansen PWTC, Baltissen MP, Valenta M, Vermeulen M, Wurst W, Gailus-Durner V, Fuchs H, Hrabe de Angelis M, Rando OJ, Kellner SM, Bultmann S, Schneider R. Genes Dev 34 715-729 (2020)
  14. N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3'-end processing. Bartosovic M, Molares HC, Gregorova P, Hrossova D, Kudla G, Vanacova S. Nucleic Acids Res. 45 11356-11370 (2017)
  15. Zc3h13 Regulates Nuclear RNA m6A Methylation and Mouse Embryonic Stem Cell Self-Renewal. Wen J, Lv R, Ma H, Shen H, He C, Wang J, Jiao F, Liu H, Yang P, Tan L, Lan F, Shi YG, He C, Shi Y, Diao J. Mol. Cell 69 1028-1038.e6 (2018)
  16. Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance. Visvanathan A, Patil V, Arora A, Hegde AS, Arivazhagan A, Santosh V, Somasundaram K. Oncogene 37 522-533 (2018)
  17. The 18S ribosomal RNA m6 A methyltransferase Mettl5 is required for normal walking behavior in Drosophila. Leismann J, Spagnuolo M, Pradhan M, Wacheul L, Vu MA, Musheev M, Mier P, Andrade-Navarro MA, Graille M, Niehrs C, Lafontaine DL, Roignant JY. EMBO Rep 21 e49443 (2020)
  18. The m6A pathway facilitates sex determination in Drosophila. Kan L, Grozhik AV, Vedanayagam J, Patil DP, Pang N, Lim KS, Huang YC, Joseph B, Lin CJ, Despic V, Guo J, Yan D, Kondo S, Deng WM, Dedon PC, Jaffrey SR, Lai EC. Nat Commun 8 15737 (2017)
  19. Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d. Knuckles P, Lence T, Haussmann IU, Jacob D, Kreim N, Carl SH, Masiello I, Hares T, Villaseñor R, Hess D, Andrade-Navarro MA, Biggiogera M, Helm M, Soller M, Bühler M, Roignant JY. Genes Dev. 32 415-429 (2018)
  20. m6A Facilitates eIF4F-Independent mRNA Translation. Coots RA, Liu XM, Mao Y, Dong L, Zhou J, Wan J, Zhang X, Qian SB. Mol. Cell 68 504-514.e7 (2017)
  21. Mettl3-/Mettl14-mediated mRNA N6-methyladenosine modulates murine spermatogenesis. Lin Z, Hsu PJ, Xing X, Fang J, Lu Z, Zou Q, Zhang KJ, Zhang X, Zhou Y, Zhang T, Zhang Y, Song W, Jia G, Yang X, He C, Tong MH. Cell Res. 27 1216-1230 (2017)
  22. Chemical Proteomic Profiling of Human Methyltransferases. Horning BD, Suciu RM, Ghadiri DA, Ulanovskaya OA, Matthews ML, Lum KM, Backus KM, Brown SJ, Rosen H, Cravatt BF. J. Am. Chem. Soc. 138 13335-13343 (2016)
  23. m6A-RNA Demethylase FTO Inhibitors Impair Self-Renewal in Glioblastoma Stem Cells. Huff S, Tiwari SK, Gonzalez GM, Wang Y, Rana TM. ACS Chem Biol 16 324-333 (2021)
  24. METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA. Wu Z, Shi Y, Lu M, Song M, Yu Z, Wang J, Wang S, Ren J, Yang YG, Liu GH, Zhang W, Ci W, Qu J. Nucleic Acids Res 48 11083-11096 (2020)
  25. N6-methyladenosine RNA modification suppresses antiviral innate sensing pathways via reshaping double-stranded RNA. Qiu W, Zhang Q, Zhang R, Lu Y, Wang X, Tian H, Yang Y, Gu Z, Gao Y, Yang X, Cui G, Sun B, Peng Y, Deng H, Peng H, Yang A, Yang YG, Yang P. Nat Commun 12 1582 (2021)
  26. Thiol-linked alkylation of RNA to assess expression dynamics. Herzog VA, Reichholf B, Neumann T, Rescheneder P, Bhat P, Burkard TR, Wlotzka W, von Haeseler A, Zuber J, Ameres SL. Nat. Methods 14 1198-1204 (2017)
  27. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA. Du M, Zhang Y, Mao Y, Mou J, Zhao J, Xue Q, Wang D, Huang J, Gao S, Gao Y. Biochem. Biophys. Res. Commun. 482 582-589 (2017)
  28. Three distinct 3-methylcytidine (m3C) methyltransferases modify tRNA and mRNA in mice and humans. Xu L, Liu X, Sheng N, Oo KS, Liang J, Chionh YH, Xu J, Ye F, Gao YG, Dedon PC, Fu XY. J. Biol. Chem. 292 14695-14703 (2017)
  29. Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis†. Li X, Xiong W, Long X, Dai X, Peng Y, Xu Y, Zhang Z, Zhang L, Liu Y. Biol Reprod 105 1221-1233 (2021)
  30. MeT-DB V2.0: elucidating context-specific functions of N6-methyl-adenosine methyltranscriptome. Liu H, Wang H, Wei Z, Zhang S, Hua G, Zhang SW, Zhang L, Gao SJ, Meng J, Chen X, Huang Y. Nucleic Acids Res. 46 D281-D287 (2018)
  31. m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Liu J, Eckert MA, Harada BT, Liu SM, Lu Z, Yu K, Tienda SM, Chryplewicz A, Zhu AC, Yang Y, Huang JT, Chen SM, Xu ZG, Leng XH, Yu XC, Cao J, Zhang Z, Liu J, Lengyel E, He C. Nat. Cell Biol. 20 1074-1083 (2018)
  32. Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism. Yang Y, Hsu PJ, Chen YS, Yang YG. Cell Res. 28 616-624 (2018)
  33. Interactions, localization, and phosphorylation of the m6A generating METTL3-METTL14-WTAP complex. Schöller E, Weichmann F, Treiber T, Ringle S, Treiber N, Flatley A, Feederle R, Bruckmann A, Meister G. RNA 24 499-512 (2018)
  34. Tag-Free Internal RNA Labeling and Photocaging Based on mRNA Methyltransferases. Ovcharenko A, Weissenboeck FP, Rentmeister A. Angew Chem Int Ed Engl 60 4098-4103 (2021)
  35. DNA N6-methyladenine in metazoans: functional epigenetic mark or bystander? Luo GZ, He C. Nat. Struct. Mol. Biol. 24 503-506 (2017)
  36. Distinguishing RNA modifications from noise in epitranscriptome maps. Grozhik AV, Jaffrey SR. Nat. Chem. Biol. 14 215-225 (2018)
  37. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer. Zhang X, Li D, Jia C, Cai H, Lv Z, Wu B. Cell Death Dis 12 617 (2021)
  38. Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates. Liu XM, Zhou J, Mao Y, Ji Q, Qian SB. Nat Chem Biol 15 865-871 (2019)
  39. Targeting the m6A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication. Burgess HM, Depledge DP, Thompson L, Srinivas KP, Grande RC, Vink EI, Abebe JS, Blackaby WP, Hendrick A, Albertella MR, Kouzarides T, Stapleford KA, Wilson AC, Mohr I. Genes Dev 35 1005-1019 (2021)
  40. m6A-Mediated Upregulation of LINC00857 Promotes Pancreatic Cancer Tumorigenesis by Regulating the miR-150-5p/E2F3 Axis. Meng X, Deng Y, He S, Niu L, Zhu H. Front Oncol 11 629947 (2021)
  41. Identification of a DNA N6-Adenine Methyltransferase Complex and Its Impact on Chromatin Organization. Beh LY, Debelouchina GT, Clay DM, Thompson RE, Lindblad KA, Hutton ER, Bracht JR, Sebra RP, Muir TW, Landweber LF. Cell 177 1781-1796.e25 (2019)
  42. N6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation. Ma H, Wang X, Cai J, Dai Q, Natchiar SK, Lv R, Chen K, Lu Z, Chen H, Shi YG, Lan F, Fan J, Klaholz BP, Pan T, Shi Y, He C. Nat. Chem. Biol. 15 88-94 (2019)
  43. m6 A deposition is regulated by PRMT1-mediated arginine methylation of METTL14 in its disordered C-terminal region. Wang Z, Pan Z, Adhikari S, Harada BT, Shen L, Yuan W, Abeywardana T, Al-Hadid Q, Stark JM, He C, Lin L, Yang Y. EMBO J 40 e106309 (2021)
  44. m6A-dependent glycolysis enhances colorectal cancer progression. Shen C, Xuan B, Yan T, Ma Y, Xu P, Tian X, Zhang X, Cao Y, Ma D, Zhu X, Zhang Y, Fang JY, Chen H, Hong J. Mol Cancer 19 72 (2020)
  45. Arginine methylation of METTL14 promotes RNA N6-methyladenosine modification and endoderm differentiation of mouse embryonic stem cells. Liu X, Wang H, Zhao X, Luo Q, Wang Q, Tan K, Wang Z, Jiang J, Cui J, Du E, Xia L, Du W, Chen D, Xia L, Xiao S. Nat Commun 12 3780 (2021)
  46. Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition. Thuy-Boun AS, Thomas JM, Grajo HL, Palumbo CM, Park S, Nguyen LT, Fisher AJ, Beal PA. Nucleic Acids Res 48 7958-7972 (2020)
  47. Decoding cyclase-dependent assembly of hapalindole and fischerindole alkaloids. Li S, Lowell AN, Newmister SA, Yu F, Williams RM, Sherman DH. Nat. Chem. Biol. 13 467-469 (2017)
  48. N6-methyladenosine is required for the hypoxic stabilization of specific mRNAs. Fry NJ, Law BA, Ilkayeva OR, Holley CL, Mansfield KD. RNA 23 1444-1455 (2017)
  49. N6-methyladenosine RNA modification regulates strawberry fruit ripening in an ABA-dependent manner. Zhou L, Tang R, Li X, Tian S, Li B, Qin G. Genome Biol 22 168 (2021)
  50. Corrigendum: Structural basis of N6-adenosine methylation by the METTL3-METTL14 complex. Wang X, Feng J, Xue Y, Guan Z, Zhang D, Liu Z, Gong Z, Wang Q, Huang J, Tang C, Zou T, Yin P. Nature 542 260 (2017)
  51. METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes. Moroz-Omori EV, Huang D, Kumar Bedi R, Cheriyamkunnel SJ, Bochenkova E, Dolbois A, Rzeczkowski MD, Li Y, Wiedmer L, Caflisch A. ChemMedChem 16 3035-3043 (2021)
  52. Methyl CpG binding protein 2 promotes colorectal cancer metastasis by regulating N6 -methyladenosine methylation through methyltransferase-like 14. Wang S, Gan M, Chen C, Zhang Y, Kong J, Zhang H, Lai M. Cancer Sci 112 3243-3254 (2021)
  53. The Major Protein Arginine Methyltransferase in Trypanosoma brucei Functions as an Enzyme-Prozyme Complex. Kafková L, Debler EW, Fisk JC, Jain K, Clarke SG, Read LK. J. Biol. Chem. 292 2089-2100 (2017)
  54. m6A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype. Liu P, Li F, Lin J, Fukumoto T, Nacarelli T, Hao X, Kossenkov AV, Simon MC, Zhang R. Nat Cell Biol 23 355-365 (2021)
  55. Degradation of WTAP blocks antiviral responses by reducing the m6 A levels of IRF3 and IFNAR1 mRNA. Ge Y, Ling T, Wang Y, Jia X, Xie X, Chen R, Chen S, Yuan S, Xu A. EMBO Rep 22 e52101 (2021)
  56. m6 A modification of HSATIII lncRNAs regulates temperature-dependent splicing. Ninomiya K, Iwakiri J, Aly MK, Sakaguchi Y, Adachi S, Natsume T, Terai G, Asai K, Suzuki T, Hirose T. EMBO J 40 e107976 (2021)
  57. A fly view on the roles and mechanisms of the m6A mRNA modification and its players. Lence T, Soller M, Roignant JY. RNA Biol 14 1232-1240 (2017)
  58. Detection of N6-methyladenosine based on the methyl-sensitivity of MazF RNA endonuclease. Imanishi M, Tsuji S, Suda A, Futaki S. Chem. Commun. (Camb.) 53 12930-12933 (2017)
  59. METTL3-mediated m6A modification regulates cell cycle progression of dental pulp stem cells. Luo H, Liu W, Zhang Y, Yang Y, Jiang X, Wu S, Shao L. Stem Cell Res Ther 12 159 (2021)
  60. N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial-Mesenchymal Transition of Cancer Cells. Li J, Chen F, Peng Y, Lv Z, Lin X, Chen Z, Wang H. Cells 9 (2020)
  61. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma. Xu H, Wang H, Zhao W, Fu S, Li Y, Ni W, Xin Y, Li W, Yang C, Bai Y, Zhan M, Lu L. Theranostics 10 5671-5686 (2020)
  62. The m6A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5'-3' exoribonuclease XRN1. Kretschmer J, Rao H, Hackert P, Sloan KE, Höbartner C, Bohnsack MT, Bohnsack MT. RNA 24 1339-1350 (2018)
  63. m6A enhances the phase separation potential of mRNA. Ries RJ, Zaccara S, Klein P, Olarerin-George A, Namkoong S, Pickering BF, Patil DP, Kwak H, Lee JH, Jaffrey SR. Nature 571 424-428 (2019)
  64. DDX5/METTL3-METTL14/YTHDF2 Axis Regulates Replication of Influenza A Virus. Zhao L, Zhao Y, Liu Q, Huang J, Lu Y, Ping J. Microbiol Spectr 10 e0109822 (2022)
  65. Fragile X mental retardation protein modulates the stability of its m6A-marked messenger RNA targets. Zhang F, Kang Y, Wang M, Li Y, Xu T, Yang W, Song H, Wu H, Shu Q, Jin P. Hum. Mol. Genet. 27 3936-3950 (2018)
  66. Hakai is required for stabilization of core components of the m6A mRNA methylation machinery. Bawankar P, Lence T, Paolantoni C, Haussmann IU, Kazlauskiene M, Jacob D, Heidelberger JB, Richter FM, Nallasivan MP, Morin V, Kreim N, Beli P, Helm M, Jinek M, Soller M, Roignant JY. Nat Commun 12 3778 (2021)
  67. N6-Allyladenosine: A New Small Molecule for RNA Labeling Identified by Mutation Assay. Shu X, Dai Q, Wu T, Bothwell IR, Yue Y, Zhang Z, Cao J, Fei Q, Luo M, He C, Liu J. J. Am. Chem. Soc. 139 17213-17216 (2017)
  68. N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma. Chen Y, Lu Z, Qi C, Yu C, Li Y, Huan W, Wang R, Luo W, Shen D, Ding L, Ren L, Xie H, Xue D, Wang M, Ni K, Xia L, Qian J, Li G. Mol Cancer 21 111 (2022)
  69. Stage-specific requirement for Mettl3-dependent m6A mRNA methylation during haematopoietic stem cell differentiation. Lee H, Bao S, Qian Y, Geula S, Leslie J, Zhang C, Hanna JH, Ding L. Nat. Cell Biol. 21 700-709 (2019)
  70. The m6A epitranscriptome opens a new charter in immune system logic. Ma Z, Gao X, Shuai Y, Xing X, Ji J. Epigenetics 16 819-837 (2021)
  71. Transcriptome-wide study revealed m6A regulation of embryonic muscle development in Dingan goose (Anser cygnoides orientalis). Xu T, Xu Z, Lu L, Zeng T, Gu L, Huang Y, Zhang S, Yang P, Wen Y, Lin D, Xing M, Huang L, Liu G, Chao Z, Sun W. BMC Genomics 22 270 (2021)
  72. m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases. Zhang W, Wang L, Zhang P, Zhang Q. Medicine (Baltimore) 100 e25952 (2021)
  73. A plant-like mechanism coupling m6A reading to polyadenylation safeguards transcriptome integrity and developmental gene partitioning in Toxoplasma. Farhat DC, Bowler MW, Communie G, Pontier D, Belmudes L, Mas C, Corrao C, Couté Y, Bougdour A, Lagrange T, Hakimi MA, Swale C. Elife 10 e68312 (2021)
  74. Crystal structure of the yeast heterodimeric ADAT2/3 deaminase. Liu X, Chen R, Sun Y, Chen R, Zhou J, Tian Q, Tao X, Zhang Z, Luo GZ, Xie W. BMC Biol 18 189 (2020)
  75. Human umbilical cord mesenchymal stem cells deliver exogenous miR-26a-5p via exosomes to inhibit nucleus pulposus cell pyroptosis through METTL14/NLRP3. Yuan X, Li T, Shi L, Miao J, Guo Y, Chen Y. Mol Med 27 91 (2021)
  76. M6A "Writer" Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer. Cai C, Long J, Huang Q, Han Y, Peng Y, Guo C, Liu S, Chen Y, Shen E, Long K, Wang X, Yu J, Shen H, Zeng S. Front Oncol 11 615296 (2021)
  77. METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity. Dou X, Huang L, Xiao Y, Liu C, Li Y, Zhang X, Yu L, Zhao R, Yang L, Chen C, Yu X, Gao B, Qi M, Gao Y, Shen B, Sun S, He C, Liu J. Protein Cell 14 683-697 (2023)
  78. METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis. Yuan X, Shi L, Guo Y, Sun J, Miao J, Shi J, Chen Y. Front Cell Dev Biol 9 629895 (2021)
  79. METTL3 regulates WTAP protein homeostasis. Sorci M, Ianniello Z, Cruciani S, Larivera S, Ginistrelli LC, Capuano E, Marchioni M, Fazi F, Fatica A. Cell Death Dis 9 796 (2018)
  80. METTL7B (methyltransferase-like 7B) identification as a novel biomarker for lung adenocarcinoma. Ali J, Liu W, Duan W, Liu C, Song J, Ali S, Li E, Wang Q. Ann Transl Med 8 1130 (2020)
  81. Programmable m6A modification of cellular RNAs with a Cas13-directed methyltransferase. Wilson C, Chen PJ, Miao Z, Liu DR. Nat Biotechnol 38 1431-1440 (2020)
  82. RNA N6-adenosine methylation (m6A) steers epitranscriptomic control of herpesvirus replication. Ye F. Inflamm Cell Signal 4 (2017)
  83. Solution structure of the RNA recognition domain of METTL3-METTL14 N6-methyladenosine methyltransferase. Huang J, Dong X, Gong Z, Qin LY, Yang S, Zhu YL, Wang X, Zhang D, Zou T, Yin P, Tang C. Protein Cell 10 272-284 (2019)
  84. The S. cerevisiae m6A-reader Pho92 promotes timely meiotic recombination by controlling key methylated transcripts. Scutenaire J, Plassard D, Matelot M, Villa T, Zumsteg J, Libri D, Séraphin B. Nucleic Acids Res 51 517-535 (2023)
  85. Letter AI-empowered integrative structural characterization of m6A methyltransferase complex. Yan X, Pei K, Guan Z, Liu F, Yan J, Jin X, Wang Q, Hou M, Tang C, Yin P. Cell Res 32 1124-1127 (2022)
  86. Alternative splicing of METTL3 explains apparently METTL3-independent m6A modifications in mRNA. Poh HX, Mirza AH, Pickering BF, Jaffrey SR. PLoS Biol 20 e3001683 (2022)
  87. Comparative Genomics and Functional Studies of Putative m6A Methyltransferase (METTL) Genes in Cotton. Cao J, Huang C, Liu J, Li C, Liu X, Zheng Z, Hou L, Huang J, Wang L, Zhang Y, Shangguan X, Chen Z. Int J Mol Sci 23 14111 (2022)
  88. Research Support, Non-U.S. Gov't Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications. Geng X, Li Z, Yang Y. Front Endocrinol (Lausanne) 13 907060 (2022)
  89. Kar4 is required for the normal pattern of meiotic gene expression. Park ZM, Remillard M, Belnap E, Rose MD. PLoS Genet 19 e1010898 (2023)
  90. Kar4, the yeast homolog of METTL14, is required for mRNA m6A methylation and meiosis. Park ZM, Sporer AJ, Kraft K, Lum KK, Blackman E, Belnap E, Yellman CM, Rose MD. PLoS Genet 19 e1010896 (2023)
  91. METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma. Li HB, Huang G, Tu J, Lv DM, Jin QL, Chen JK, Zou YT, Lee DF, Shen JN, Xie XB. EBioMedicine 82 104142 (2022)
  92. METTL4 catalyzes m6Am methylation in U2 snRNA to regulate pre-mRNA splicing. Goh YT, Koh CWQ, Sim DY, Roca X, Goh WSS. Nucleic Acids Res 48 9250-9261 (2020)
  93. Marking RNA: m6A writers, readers, and functions in Arabidopsis. Reichel M, Köster T, Staiger D. J Mol Cell Biol 11 899-910 (2019)
  94. Mechanistic insights into m6A modification of U6 snRNA by human METTL16. Aoyama T, Yamashita S, Tomita K. Nucleic Acids Res 48 5157-5168 (2020)
  95. Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development. Mendel M, Chen KM, Homolka D, Gos P, Pandey RR, McCarthy AA, Pillai RS. Mol. Cell 71 986-1000.e11 (2018)
  96. Mettl14-mediated m6A modification is essential for visual function and retinal photoreceptor survival. Yang Y, Shuai P, Li X, Sun K, Jiang X, Liu W, Le W, Jiang H, Liu Y, Zhu X. BMC Biol 20 140 (2022)
  97. Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Wu Y, Xie L, Wang M, Xiong Q, Guo Y, Liang Y, Li J, Sheng R, Deng P, Wang Y, Zheng R, Jiang Y, Ye L, Chen Q, Zhou X, Lin S, Yuan Q. Nat Commun 9 4772 (2018)
  98. Opposing regulation of the Nα-trimethylase METTL11A by its family members METTL11B and METTL13. Parker HV, Schaner Tooley CE. J Biol Chem 299 104588 (2023)
  99. PLAA suppresses ovarian cancer metastasis via METTL3-mediated m6A modification of TRPC3 mRNA. Shen Z, Gu L, Liu Y, Wang L, Zhu J, Tang S, Wei X, Wang J, Zhang S, Wang X, Cheng X, Xie X, Lu W. Oncogene 41 4145-4158 (2022)
  100. Post-transcriptional regulation by the exosome complex is required for cell survival and forebrain development via repression of P53 signaling. Ulmke PA, Xie Y, Sokpor G, Pham L, Shomroni O, Berulava T, Rosenbusch J, Basu U, Fischer A, Nguyen HP, Staiger JF, Tuoc T. Development 148 dev188276 (2021)
  101. RNA m6 A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy. Lin Z, Niu Y, Wan A, Chen D, Liang H, Chen X, Sun L, Zhan S, Chen L, Cheng C, Zhang X, Bu X, He W, Wan G. EMBO J 39 e103181 (2020)
  102. Structural Basis for Regulation of METTL16, an S-Adenosylmethionine Homeostasis Factor. Doxtader KA, Wang P, Scarborough AM, Seo D, Conrad NK, Nam Y. Mol. Cell 71 1001-1011.e4 (2018)
  103. The RNA helicase DDX5 promotes viral infection via regulating N6-methyladenosine levels on the DHX58 and NFκB transcripts to dampen antiviral innate immunity. Xu J, Cai Y, Ma Z, Jiang B, Liu W, Cheng J, Guo N, Wang Z, Sealy JE, Song C, Wang X, Li Y. PLoS Pathog 17 e1009530 (2021)
  104. Vir1p, the yeast homolog of virilizer, is required for mRNA m6A methylation and meiosis. Park ZM, Belnap E, Remillard M, Rose MD. Genetics 224 iyad043 (2023)
  105. A cleaved METTL3 potentiates the METTL3-WTAP interaction and breast cancer progression. Yan C, Xiong J, Zhou Z, Li Q, Gao C, Zhang M, Yu L, Li J, Hu MM, Zhang CS, Cai C, Zhang H, Zhang J. Elife 12 RP87283 (2023)
  106. Aberrant expression of enzymes regulating m6A mRNA methylation: implication in cancer. Pinello N, Sun S, Wong JJ. Cancer Biol Med 15 323-334 (2018)
  107. Acute depletion of METTL3 implicates N 6-methyladenosine in alternative intron/exon inclusion in the nascent transcriptome. Wei G, Almeida M, Pintacuda G, Coker H, Bowness JS, Ule J, Brockdorff N. Genome Res 31 1395-1408 (2021)
  108. Adipose METTL14-Elicited N6 -Methyladenosine Promotes Obesity, Insulin Resistance, and NAFLD Through Suppressing β Adrenergic Signaling and Lipolysis. Kang Q, Zhu X, Ren D, Ky A, MacDougald OA, O'Rourke RW, Rui L. Adv Sci (Weinh) 10 e2301645 (2023)
  109. Alphaherpesvirus US3 protein-mediated inhibition of the m6A mRNA methyltransferase complex. Jansens RJJ, Verhamme R, Mirza AH, Olarerin-George A, Van Waesberghe C, Jaffrey SR, Favoreel HW. Cell Rep 40 111107 (2022)
  110. Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancer. Lothion-Roy J, Haigh DB, Harris AE, Metzler VM, Alsaleem M, Toss MS, Kariri Y, Ntekim A, Robinson BD, Khani F, Gudas LJ, Allegrucci C, James VH, Madhusudan S, Mather M, Emes RD, Archer N, Fray RG, Rakha E, Jeyapalan JN, Rutland CS, Mongan NP, Woodcock CL. Front Genet 13 1096071 (2022)
  111. Comparative Phylogenomic Analysis Reveals Evolutionary Genomic Changes and Novel Toxin Families in Endophytic Liberibacter Pathogens. Tan Y, Wang C, Schneider T, Li H, de Souza RF, Tang X, Swisher Grimm KD, Hsieh TF, Wang X, Li X, Zhang D. Microbiol Spectr 9 e0050921 (2021)
  112. DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m6A modification and translation for cytoprotective autophagy in cervical cancer. Shen W, Zhu M, Wang Q, Zhou X, Wang J, Wang T, Zhang J. RNA Biol 19 751-763 (2022)
  113. DaReUS-Loop: accurate loop modeling using fragments from remote or unrelated proteins. Karami Y, Guyon F, De Vries S, Tufféry P. Sci Rep 8 13673 (2018)
  114. Evolution of Methyltransferase-Like (METTL) Proteins in Metazoa: A Complex Gene Family Involved in Epitranscriptomic Regulation and Other Epigenetic Processes. Wong JM, Eirin-Lopez JM. Mol Biol Evol 38 5309-5327 (2021)
  115. Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis. Zhou Y, Jiang R, Jiang Y, Fu Y, Manafhan Y, Zhu J, Jia E. Cells 11 2980 (2022)
  116. FIONA1 is an RNA N6-methyladenosine methyltransferase affecting Arabidopsis photomorphogenesis and flowering. Wang C, Yang J, Song P, Zhang W, Lu Q, Yu Q, Jia G. Genome Biol 23 40 (2022)
  117. GR-mediated transcriptional regulation of m6A metabolic genes contributes to diet-induced fatty liver in hens. Feng Y, Li Y, Jiang W, Hu Y, Jia Y, Zhao R. J Anim Sci Biotechnol 12 117 (2021)
  118. Introducing selective agrochemical manipulation of gibberellin metabolism into a cereal crop. Zhang J, Zhang Y, Xing J, Yu H, Zhang R, Chen Y, Zhang D, Yin P, Tian X, Wang Q, Duan L, Zhang M, Peters RJ, Li Z. Nat Plants 6 67-72 (2020)
  119. METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cells. Hou Y, Zhang X, Yao H, Hou L, Zhang Q, Tao E, Zhu X, Jiang S, Ren Y, Hong X, Lu S, Leng X, Xie Y, Gao Y, Liang Y, Zhong T, Long B, Fang JY, Meng X. EMBO Rep 24 e56325 (2023)
  120. METTL3 promotes cell cycle progression via m6A/YTHDF1-dependent regulation of CDC25B translation. Li H, Zhong Y, Cao G, Shi H, Liu Y, Li L, Yin P, Chen J, Xiao Z, Du B. Int J Biol Sci 18 3223-3236 (2022)
  121. METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. Zeng ZC, Pan Q, Sun YM, Huang HJ, Chen XT, Chen TQ, He B, Ye H, Zhu SX, Pu KJ, Fang K, Huang W, Chen YQ, Wang WT. EMBO Rep 24 e55762 (2023)
  122. METTL3-mediated m6A RNA methylation regulates dorsal lingual epithelium homeostasis. Xiong Q, Liu C, Zheng X, Zhou X, Lei K, Zhang X, Wang Q, Lin W, Tong R, Xu R, Yuan Q. Int J Oral Sci 14 26 (2022)
  123. Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a. Xu Y, Zhou Z, Kang X, Pan L, Liu C, Liang X, Chu J, Dong S, Li Y, Liu Q, Sun Y, Yu S, Zhang Q. Nat Commun 13 4555 (2022)
  124. N6-Methyladenosine dynamic changes and differential methylation in wheat grain development. Li W, Yu Y, Chen X, Fang Q, Yang A, Chen X, Wu L, Wang C, Wu D, Ye S, Wu D, Sun G. Planta 255 125 (2022)
  125. N6-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression. Fry NJ, Law BA, Ilkayeva OR, Carraway KR, Holley CL, Mansfield KD. Oncotarget 9 31231-31243 (2018)
  126. Regulation of telomere homeostasis and genomic stability in cancer by N6-adenosine methylation (m6A). Lee JH, Hong J, Zhang Z, de la Peña Avalos B, Proietti CJ, Deamicis AR, Guzmán G P, Lam HM, Garcia J, Roudier MP, Sisk AE, De La Rosa R, Vu K, Yang M, Liao Y, Scheirer J, Pechacek D, Yadav P, Rao MK, Zheng S, Johnson-Pais TL, Leach RJ, Elizalde PV, Dray E, Xu K. Sci Adv 7 eabg7073 (2021)
  127. Relaxed initiation pausing of ribosomes drives oncogenic translation. Dong L, Mao Y, Zhou A, Liu XM, Zhou J, Wan J, Qian SB. Sci Adv 7 eabd6927 (2021)
  128. Structural and Virus Regulatory Insights Into Avian N6-Methyladenosine (m6A) Machinery. Bayoumi M, Rohaim MA, Munir M. Front Cell Dev Biol 8 543 (2020)
  129. Structures of the m(6)A Methyltransferase Complex: Two Subunits with Distinct but Coordinated Roles. Zhou KI, Pan T. Mol. Cell 63 183-185 (2016)
  130. WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m6A-dependent manner. Chen S, Li Y, Zhi S, Ding Z, Wang W, Peng Y, Huang Y, Zheng R, Yu H, Wang J, Hu M, Miao J, Li J. Cell Death Dis 11 659 (2020)
  131. YTHDF3 modulates hematopoietic stem cells by recognizing RNA m6A modification on Ccnd1. Zhang X, Cong T, Wei L, Zhong B, Wang X, Sun J, Wang S, Xu MM, Zhu P, Jiang H, Wang J. Haematologica 107 2381-2394 (2022)
  132. m6A RNA methylation of major satellite repeat transcripts facilitates chromatin association and RNA:DNA hybrid formation in mouse heterochromatin. Duda KJ, Ching RW, Jerabek L, Shukeir N, Erikson G, Engist B, Onishi-Seebacher M, Perrera V, Richter F, Mittler G, Fritz K, Helm M, Knuckles P, Bühler M, Jenuwein T. Nucleic Acids Res 49 5568-5587 (2021)
  133. m6A-express: uncovering complex and condition-specific m6A regulation of gene expression. Zhang T, Zhang SW, Zhang SY, Gao SJ, Chen Y, Huang Y. Nucleic Acids Res 49 e116 (2021)
  134. β-catenin represses miR455-3p to stimulate m6A modification of HSF1 mRNA and promote its translation in colorectal cancer. Song P, Feng L, Li J, Dai D, Zhu L, Wang C, Li J, Li L, Zhou Q, Shi R, Wang X, Jin H. Mol Cancer 19 129 (2020)
  135. 7SK methylation by METTL3 promotes transcriptional activity. Perez-Pepe M, Desotell AW, Li H, Li W, Han B, Lin Q, Klein DE, Liu Y, Goodarzi H, Alarcón CR. Sci Adv 9 eade7500 (2023)
  136. A common transcriptional mechanism involving R-loop and RNA abasic site regulates an enhancer RNA of APOE. Watts JA, Grunseich C, Rodriguez Y, Liu Y, Li D, Burdick JT, Bruzel A, Crouch RJ, Mahley RW, Wilson SH, Cheung VG. Nucleic Acids Res 50 12497-12514 (2022)
  137. A deregulated m6A writer complex axis driven by BRD4 confers an epitranscriptomic vulnerability in combined DNA repair-targeted therapy. Lu X, Peng L, Ding J, Li Y, Li Q, Rao M, Shu T, He X, Liu C, Ye J, Liu W, You H. Proc Natl Acad Sci U S A 120 e2304534120 (2023)
  138. A fluorescent methylation-switchable probe for highly sensitive analysis of FTO N 6-methyladenosine demethylase activity in cells. Cheong A, Low JJA, Lim A, Yen PM, Woon ECY. Chem Sci 9 7174-7185 (2018)
  139. A novel m6A/m5C/m1A score signature to evaluate prognosis and its immunotherapy value in colon cancer patients. Liu J, Dou M, Liu X, Lu Y, Lu W. J Cancer Res Clin Oncol 149 11995-12012 (2023)
  140. A programmable system to methylate and demethylate N6-methyladenosine (m6A) on specific RNA transcripts in mammalian cells. Chang C, Ma G, Cheung E, Hutchins AP. J Biol Chem 298 102525 (2022)
  141. ATP-Independent Initiation during Cap-Independent Translation of m6A-Modified mRNA. Sakharov PA, Smolin EA, Lyabin DN, Agalarov SC. Int J Mol Sci 22 3662 (2021)
  142. Alteration of N6-Methyladenosine RNA Profiles in Cisplatin-Induced Acute Kidney Injury in Mice. Li CM, Li M, Zhao WB, Ye ZC, Peng H. Front Mol Biosci 8 654465 (2021)
  143. An Exploration of the Coherent Effects between METTL3 and NDUFA10 on Alzheimer's Disease. Yang L, Pang X, Guo W, Zhu C, Yu L, Song X, Wang K, Pang C. Int J Mol Sci 24 10111 (2023)
  144. Analysis of N6-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction. Huang JB, Hu BB, He R, He L, Zou C, Man CF, Fan Y. Front Genet 12 787800 (2021)
  145. Association between ankylosing spondylitis and m6A methylation. Luan Z, Wang Y. J Orthop Surg Res 18 757 (2023)
  146. Atlas of quantitative single-base-resolution N6-methyl-adenine methylomes. Koh CWQ, Goh YT, Goh WSS. Nat Commun 10 5636 (2019)
  147. Bisubstrate analogues as structural tools to investigate m6A methyltransferase active sites. Oerum S, Catala M, Atdjian C, Brachet F, Ponchon L, Barraud P, Iannazzo L, Droogmans L, Braud E, Ethève-Quelquejeu M, Tisné C. RNA Biol 16 798-808 (2019)
  148. CMTr mediated 2'-O-ribose methylation status of cap-adjacent nucleotides across animals. Dix TC, Haussmann IU, Brivio S, Nallasivan MP, HadzHiev Y, Müller F, Müller B, Pettitt J, Soller M. RNA 28 1377-1390 (2022)
  149. Changes in N6-Methyladenosine Modification Modulate Diabetic Cardiomyopathy by Reducing Myocardial Fibrosis and Myocyte Hypertrophy. Ju W, Liu K, Ouyang S, Liu Z, He F, Wu J. Front Cell Dev Biol 9 702579 (2021)
  150. Comprehensive analysis of N6-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in bladder cancer. Cui J, Zhu Y, Liu X, Wang W, Jiang X, Xia Y, Zhou G, Chen S, Shi B. Cancer Cell Int 22 72 (2022)
  151. Comprehensive profiling analysis of the N6-methyladenosine-modified circular RNA transcriptome in cultured cells infected with Marek's disease virus. Sun A, Wang R, Yang S, Zhu X, Liu Y, Teng M, Zheng L, Luo J, Zhang G, Zhuang G. Sci Rep 11 11084 (2021)
  152. Cryo-EM structures of human m6A writer complexes. Su S, Li S, Deng T, Gao M, Yin Y, Wu B, Peng C, Liu J, Ma J, Zhang K. Cell Res 32 982-994 (2022)
  153. Crystal structure of ErmE - 23S rRNA methyltransferase in macrolide resistance. Stsiapanava A, Selmer M. Sci Rep 9 14607 (2019)
  154. Deep learning modeling m6A deposition reveals the importance of downstream cis-element sequences. Luo Z, Zhang J, Fei J, Ke S. Nat Commun 13 2720 (2022)
  155. Deletion of Mettl3 at the Pro-B Stage Marginally Affects B Cell Development and Profibrogenic Activity of B Cells in Liver Fibrosis. Kang X, Chen S, Pan L, Liang X, Lu D, Chen H, Li Y, Liu C, Ge M, Zhang Q, Liu Q, Xu Y. J Immunol Res 2022 8118577 (2022)
  156. Deoxycholic acid modulates the progression of gallbladder cancer through N6-methyladenosine-dependent microRNA maturation. Lin R, Zhan M, Yang L, Wang H, Shen H, Huang S, Huang X, Xu S, Zhang Z, Li W, Liu Q, Shi Y, Chen W, Yu J, Wang J. Oncogene 39 4983-5000 (2020)
  157. Detailed modeling of positive selection improves detection of cancer driver genes. Zhao S, Liu J, Nanga P, Liu Y, Cicek AE, Knoblauch N, He C, Stephens M, He X. Nat Commun 10 3399 (2019)
  158. Diagnostic, Therapeutic, and Prognostic Value of the m6A Writer Complex in Hepatocellular Carcinoma. Gu Z, Du Y, Zhao X, Wang C. Front Cell Dev Biol 10 822011 (2022)
  159. Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products. Du Y, Yuan Y, Xu L, Zhao F, Wang W, Xu Y, Tian X. Front Pharmacol 13 878135 (2022)
  160. Distinct roles of Fto and Mettl3 in controlling development of the cerebral cortex through transcriptional and translational regulations. Du K, Zhang Z, Zeng Z, Tang J, Lee T, Sun T. Cell Death Dis 12 700 (2021)
  161. Dynamic assembly of the mRNA m6A methyltransferase complex is regulated by METTL3 phase separation. Han D, Longhini AP, Zhang X, Hoang V, Wilson MZ, Kosik KS. PLoS Biol 20 e3001535 (2022)
  162. Dynamic control of chromatin-associated m6A methylation regulates nascent RNA synthesis. Xu W, He C, Kaye EG, Li J, Mu M, Nelson GM, Dong L, Wang J, Wu F, Shi YG, Adelman K, Lan F, Shi Y, Shen H. Mol Cell 82 1156-1168.e7 (2022)
  163. Dysregulation and implications of N6-methyladenosine modification in renal cell carcinoma. Wu Y, Zhang S, Chen C, Pang J. Curr Urol 17 45-51 (2023)
  164. Effects of Gestational Arsenic Exposures on Placental and Fetal Development in Mice: The Role of Cyr61 m6A. Song YP, Lv JW, Zhang ZC, Qian QH, Fan YJ, Chen DZ, Zhang H, Xu FX, Zhang C, Huang Y, Wang H, Wei W, Xu DX. Environ Health Perspect 131 97004 (2023)
  165. Eltrombopag as an Allosteric Inhibitor of the METTL3-14 Complex Affecting the m6A Methylation of RNA in Acute Myeloid Leukemia Cells. Lee JH, Choi N, Kim S, Jin MS, Shen H, Kim YC. Pharmaceuticals (Basel) 15 440 (2022)
  166. Elucidating the Kinetic Mechanism of Human METTL16. Breger K, Brown JA. Biochemistry 62 494-506 (2023)
  167. Episo: quantitative estimation of RNA 5-methylcytosine at isoform level by high-throughput sequencing of RNA treated with bisulfite. Liu J, An Z, Luo J, Li J, Li F, Zhang Z. Bioinformatics 36 2033-2039 (2020)
  168. Epitranscriptic regulation of HRAS by N6-methyladenosine drives tumor progression. Pan Y, Gu Y, Liu T, Zhang Q, Yang F, Duan L, Cheng S, Zhu X, Xi Y, Chang X, Ye Q, Gao S. Proc Natl Acad Sci U S A 120 e2302291120 (2023)
  169. Erasing m6A-dependent transcription signature of stress-sensitive genes triggers antidepressant actions. Wu PF, Han QQ, Chen FF, Shen TT, Li YH, Cao Y, Chen JG, Wang F. Neurobiol Stress 15 100390 (2021)
  170. Exploring diagnostic m6A regulators in endometriosis. Jiang L, Zhang M, Wu J, Wang S, Yang X, Yi M, Zhang X, Fang X. Aging (Albany NY) 12 25916-25938 (2020)
  171. FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA. Gan X, Dai Z, Ge C, Yin H, Wang Y, Tan J, Sun S, Zhou W, Yuan S, Yang F. Front Oncol 12 989353 (2022)
  172. Formation and removal of 1,N6-dimethyladenosine in mammalian transfer RNA. You XJ, Zhang S, Chen JJ, Tang F, He J, Wang J, Qi CB, Feng YQ, Yuan BF. Nucleic Acids Res 50 9858-9872 (2022)
  173. Fumonisin B1 alters global m6A RNA methylation and epigenetically regulates Keap1-Nrf2 signaling in human hepatoma (HepG2) cells. Arumugam T, Ghazi T, Chuturgoon AA. Arch Toxicol (2021)
  174. Functional Characterization of Two RNA Methyltransferase Genes METTL3 and METTL14 Uncovers the Roles of m6A in Mediating Adaptation of Plutella xylostella to Host Plants. Wang BB, Lai YF, Li FF, Jiao L, Qiao QX, Li SY, Xiang XJ, Liao H, You MS, He WY. Int J Mol Sci 23 10013 (2022)
  175. Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma. Chang X, Lv YF, He J, Cao Y, Li CQ, Guo QN. J Hepatocell Carcinoma 8 85-101 (2021)
  176. Global Landscape of m6A Methylation of Differently Expressed Genes in Muscle Tissue of Liaoyu White Cattle and Simmental Cattle. Dang Y, Dong Q, Wu B, Yang S, Sun J, Cui G, Xu W, Zhao M, Zhang Y, Li P, Li L. Front Cell Dev Biol 10 840513 (2022)
  177. HIV Replication Is Increased by RNA Methylation METTL3/METTL14/WTAP Complex Activators. Selberg S, Žusinaite E, Herodes K, Seli N, Kankuri E, Merits A, Karelson M. ACS Omega 6 15957-15963 (2021)
  178. Increased METTL3-mediated m6A methylation inhibits embryo implantation by repressing HOXA10 expression in recurrent implantation failure. Xue P, Zhou W, Fan W, Jiang J, Kong C, Zhou W, Zhou J, Huang X, Yang H, Han Q, Zhang B, Xu L, Yu B, Chen L. Reprod Biol Endocrinol 19 187 (2021)
  179. Increased expression of METTL3 in pancreatic cancer tissues associates with poor survival of the patients. Li Y, Huang H, Zhu Y, Xu B, Chen J, Liu Y, Zheng X, Chen L. World J Surg Oncol 20 283 (2022)
  180. Inducible and reversible RNA N6-methyladenosine editing. Shi H, Xu Y, Tian N, Yang M, Liang FS. Nat Commun 13 1958 (2022)
  181. Integrative Analysis of N6-Methyladenosine-Related Enhancer RNAs Identifies Distinct Prognosis and Tumor Immune Micro-Environment Patterns in Head and Neck Squamous Cell Carcinoma. Cai H, Liang J, Jiang Y, Tan R, Hou C, Hou J. Cancers (Basel) 14 4657 (2022)
  182. Intestinal transit-amplifying cells require METTL3 for growth factor signaling and cell survival. Danan CH, Naughton KE, Hayer KE, Vellappan S, McMillan EA, Zhou Y, Matsuda R, Nettleford SK, Katada K, Parham LR, Ma X, Chowdhury A, Wilkins BJ, Shah P, Weitzman MD, Hamilton KE. JCI Insight 8 e171657 (2023)
  183. Knockdown of METTL14 suppresses the malignant progression of non-small cell lung cancer by reducing Twist expression. Yang F, Yuan WQ, Li J, Luo YQ. Oncol Lett 22 847 (2021)
  184. Knockdown of METTL16 disrupts learning and memory by reducing the stability of MAT2A mRNA. Zhang R, Zhang Y, Guo F, Huang G, Zhao Y, Chen B, Wang C, Cui C, Shi Y, Li S, Cui H. Cell Death Discov 8 432 (2022)
  185. Knockdown of lncRNA NUTM2A-AS1 inhibits lung adenocarcinoma cell viability by regulating the miR-590-5p/METTL3 axis. Wang J, Zha J, Wang X. Oncol Lett 22 798 (2021)
  186. Light-induced LLPS of the CRY2/SPA1/FIO1 complex regulating mRNA methylation and chlorophyll homeostasis in Arabidopsis. Jiang B, Zhong Z, Gu L, Zhang X, Wei J, Ye C, Lin G, Qu G, Xiang X, Wen C, Hummel M, Bailey-Serres J, Wang Q, He C, Wang X, Lin C. Nat Plants 9 2042-2058 (2023)
  187. METTL14 is required for exercise-induced cardiac hypertrophy and protects against myocardial ischemia-reperfusion injury. Wang L, Wang J, Yu P, Feng J, Xu GE, Zhao X, Wang T, Lehmann HI, Li G, Sluijter JPG, Xiao J. Nat Commun 13 6762 (2022)
  188. METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination. Shen D, Ding L, Lu Z, Wang R, Yu C, Wang H, Zheng Q, Wang X, Xu W, Yu H, Xu L, Wang M, Yu S, Zhu S, Qian J, Xia L, Li G. Mol Ther Nucleic Acids 27 547-561 (2022)
  189. METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis. Su R, Dong L, Li Y, Gao M, He PC, Liu W, Wei J, Zhao Z, Gao L, Han L, Deng X, Li C, Prince E, Tan B, Qing Y, Qin X, Shen C, Xue M, Zhou K, Chen Z, Xue J, Li W, Qin H, Wu X, Sun M, Nam Y, Chen CW, Huang W, Horne D, Rosen ST, He C, Chen J. Nat Cell Biol 24 205-216 (2022)
  190. METTL3 Promotes the Differentiation of Goat Skeletal Muscle Satellite Cells by Regulating MEF2C mRNA Stability in a m6A-Dependent Manner. Zhao S, Cao J, Sun Y, Zhou H, Zhu Q, Dai D, Zhan S, Guo J, Zhong T, Wang L, Li L, Zhang H. Int J Mol Sci 24 14115 (2023)
  191. METTL3 Promotes the Proliferation and Mobility of Gastric Cancer Cells. Lin S, Liu J, Jiang W, Wang P, Sun C, Wang X, Chen Y, Wang H. Open Med (Wars) 14 25-31 (2019)
  192. METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer. Ouyang D, Hong T, Fu M, Li Y, Zeng L, Chen Q, He H, Wen Y, Cheng Y, Zhou M, Zou Q, Yi W. Breast Cancer Res 25 19 (2023)
  193. METTL3 enhances dentinogenesis differentiation of dental pulp stem cells via increasing GDF6 and STC1 mRNA stability. Pan Y, Liu Y, Cui D, Yu S, Zhou Y, Zhou X, Du W, Zheng L, Wan M. BMC Oral Health 23 209 (2023)
  194. METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4. Li M, Ye J, Xia Y, Li M, Li G, Hu X, Su X, Wang D, Zhao X, Lu F, Li J, Ma D, Sun T, Ji C. Leukemia 36 2586-2595 (2022)
  195. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy. Sun Y, Shen W, Hu S, Lyu Q, Wang Q, Wei T, Zhu W, Zhang J. J Exp Clin Cancer Res 42 65 (2023)
  196. METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway. Sun Y, Gong W, Zhang S. Cell Death Dis 14 765 (2023)
  197. METTL3 promotes microglial inflammation via MEF2C in spinal cord injury. Wang D, Qian W, Wu D, Wu Y, Lu K, Zou G. Cell Tissue Res (2024)
  198. METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability. Xu Y, Bao Y, Qiu G, Ye H, He M, Wei X. Mol Med Rep 28 217 (2023)
  199. METTL3-mediated long non-coding RNA MIR99AHG methylation targets miR-4660 to promote bone marrow mesenchymal stem cell osteogenic differentiation. Li L, Wang B, Zhou X, Ding H, Sun C, Wang Y, Zhang F, Zhao J. Cell Cycle 22 476-493 (2023)
  200. METTL3/m6A/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma. Ge F, Li Z, Hu J, Pu Y, Zhao F, Kong L. Front Pharmacol 13 1002565 (2022)
  201. METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer. Liu D, Li W, Zhong F, Yin J, Zhou W, Li S, Sun X, Xu J, Li G, Wen Y, Wang J, Hong M, Cheng Z, Yuan J, Dai L, Sun J, Wang J, Qiu C, Wang G, Zou C. Front Pharmacol 11 178 (2020)
  202. MePMe-seq: antibody-free simultaneous m6A and m5C mapping in mRNA by metabolic propargyl labeling and sequencing. Hartstock K, Kueck NA, Spacek P, Ovcharenko A, Hüwel S, Cornelissen NV, Bollu A, Dieterich C, Rentmeister A. Nat Commun 14 7154 (2023)
  203. Methyltransferase like 3-mediated N6-methylatidin methylation inhibits vascular smooth muscle cells phenotype switching via promoting phosphatidylinositol 3-kinase mRNA decay. Zhao Y, Xia A, Li C, Long X, Bai Z, Qiu Z, Xiong W, Gu N, Shen Y, Zhao R, Shi B. Front Cardiovasc Med 9 913039 (2022)
  204. Mettl14-driven senescence-associated secretory phenotype facilitates somatic cell reprogramming. Xi C, Sun J, Xu X, Wu Y, Kou X, Zhao Y, Shen J, Dong Y, Chen K, Su Z, Liu D, Ye W, Liu Y, Zhang R, Xu Y, Wang H, Hao L, Wu L, Gao S. Stem Cell Reports 17 1799-1809 (2022)
  205. Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation. Wang H, Hu X, Huang M, Liu J, Gu Y, Ma L, Zhou Q, Cao X. Nat Commun 10 1898 (2019)
  206. N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast Cancer. Song Y, Zheng C, Tao Y, Huang R, Zhang Q. Med Sci Monit 27 e929615 (2021)
  207. N6-methyladenosine (m6A) methyltransferase WTAP-mediated miR-92b-5p accelerates osteoarthritis progression. Lin Z, Jiang T, Zheng W, Zhang J, Li A, Lu C, Liu W. Cell Commun Signal 21 199 (2023)
  208. N6-methyladenosine RNA modification promotes viral genomic RNA stability and infection. Zhang T, Shi C, Hu H, Zhang Z, Wang Z, Chen Z, Feng H, Liu P, Guo J, Lu Q, Zhong K, Chen Z, Liu J, Yu J, Chen J, Chen F, Yang J. Nat Commun 13 6576 (2022)
  209. N6-methyladenosine RNA modification regulates cotton drought response in a Ca2+ and ABA-dependent manner. Li B, Zhang M, Sun W, Yue D, Ma Y, Zhang B, Duan L, Wang M, Lindsey K, Nie X, Zhang X, Yang X. Plant Biotechnol J 21 1270-1285 (2023)
  210. N6-methyladenosine modification governs liver glycogenesis by stabilizing the glycogen synthase 2 mRNA. Zhang X, Yin H, Zhang X, Jiang X, Liu Y, Zhang H, Peng Y, Li D, Yu Y, Zhang J, Cheng S, Yang A, Zhang R. Nat Commun 13 7038 (2022)
  211. N6-methyladenosine regulates ATM expression and downstream signaling. Zhang X, Liu P, Zheng X, Wang J, Peng Q, Li Z, Wei L, Liu C, Wu Y, Wen Y, Yan Q, Ma J. J Cancer 12 7041-7051 (2021)
  212. N6‑methyladenosine upregulates miR‑181d‑5p in exosomes derived from cancer‑associated fibroblasts to inhibit 5‑FU sensitivity by targeting NCALD in colorectal cancer. Pan S, Deng Y, Fu J, Zhang Y, Zhang Z, Qin X. Int J Oncol 60 14 (2022)
  213. N6 -Methyladenosine Modification in Chronic Stress Response Due to Social Hierarchy Positioning of Mice. Dos Santos Guilherme M, Tsoutsouli T, Todorov H, Teifel S, Nguyen VTT, Gerber S, Endres K. Front Cell Dev Biol 9 705986 (2021)
  214. N6-Adenosine Methylation in RNA and a Reduced m3G/TMG Level in Non-Coding RNAs Appear at Microirradiation-Induced DNA Lesions. Svobodová Kovaříková A, Stixová L, Kovařík A, Komůrková D, Legartová S, Fagherazzi P, Bártová E. Cells 9 (2020)
  215. N6-Methyladenosine RNA Modification in Normal and Malignant Hematopoiesis. Weng H, Huang H, Chen J. Adv Exp Med Biol 1442 105-123 (2023)
  216. N6-methyladenosine is required for efficient RNA synthesis of Ebola virus and other haemorrhagic fever viruses. Wendt L, Pickin MJ, Bodmer BS, Reiche S, Fénéant L, Hölper JE, Fuchs W, Groseth A, Hoenen T. Emerg Microbes Infect 12 2223732 (2023)
  217. N6-methyladenosine modification of the Aedes aegypti transcriptome and its alteration upon dengue virus infection in Aag2 cell line. Dai Z, Etebari K, Asgari S. Commun Biol 5 607 (2022)
  218. Novel Roles of RNA m6A Methylation Regulators in the Occurrence of Alzheimer's Disease and the Subtype Classification. Li M, Cheng W, Zhang L, Zhou C, Peng X, Yu S, Zhang W. Int J Mol Sci 23 10766 (2022)
  219. Novel insights into the regulatory role of N6-methyladenosine methylation modified autophagy in sepsis. Bi CF, Liu J, Hu XD, Yang LS, Zhang JF. Aging (Albany NY) 15 15676-15700 (2023)
  220. O-GlcNAcylation determines the translational regulation and phase separation of YTHDF proteins. Chen Y, Wan R, Zou Z, Lao L, Shao G, Zheng Y, Tang L, Yuan Y, Ge Y, He C, Lin S. Nat Cell Biol 25 1676-1690 (2023)
  221. PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m6A methylation to control cancer cell radiosensitivity. Sun X, Bai C, Li H, Xie D, Chen S, Han Y, Luo J, Li Y, Ye Y, Jia J, Huang X, Guan H, Long D, Huang R, Gao S, Zhou PK. Mol Ther 31 2633-2650 (2023)
  222. PRMT1 methylates METTL14 to modulate its oncogenic function. Wang J, Wang Z, Inuzuka H, Wei W, Liu J. Neoplasia 42 100912 (2023)
  223. Predict Epitranscriptome Targets and Regulatory Functions of N 6-Methyladenosine (m6A) Writers and Erasers. Song Y, Xu Q, Wei Z, Zhen D, Su J, Chen K, Meng J. Evol. Bioinform. Online 15 1176934319871290 (2019)
  224. Prediction of RNA Methylation Status From Gene Expression Data Using Classification and Regression Methods. Xue H, Wei Z, Chen K, Tang Y, Wu X, Su J, Meng J. Evol Bioinform Online 16 1176934320915707 (2020)
  225. Prognostic Values of METTL3 and Its Roles in Tumor Immune Microenvironment in Pan-Cancer. Guo Y, Heng Y, Chen H, Huang Q, Wu C, Tao L, Zhou L. J Clin Med 12 155 (2022)
  226. RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation. Dou X, Xiao Y, Shen C, Wang K, Wu T, Liu C, Li Y, Yu X, Liu J, Dai Q, Pajdzik K, Ye C, Ge R, Gao B, Yu J, Sun S, Chen M, Chen J, He C. Nat Cell Biol 25 1359-1368 (2023)
  227. RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4. Fang J, Wu X, He J, Zhang H, Chen X, Zhang H, Novakovic B, Qi H, Yu X. Mol Med 29 23 (2023)
  228. RNA Modifications in Hematologic Malignancies. Li Y, Tian W, Zhang H. Cancer Treat Res 190 181-207 (2023)
  229. RNA binding protein RBM46 regulates mitotic-to-meiotic transition in spermatogenesis. Qian B, Li Y, Yan R, Han S, Bu Z, Gong J, Zheng B, Yuan Z, Ren S, He Q, Zhang J, Xu C, Wang R, Sun Z, Lin M, Zhou J, Ye L. Sci Adv 8 eabq2945 (2022)
  230. RNA binding to human METTL3-METTL14 restricts N6-deoxyadenosine methylation of DNA in vitro. Qi S, Mota J, Chan SH, Villarreal J, Dai N, Arya S, Hromas RA, Rao MK, Corrêa IR, Gupta YK. Elife 11 e67150 (2022)
  231. RNA m6A Methylation Regulators Subclassify Luminal Subtype in Breast Cancer. Yang L, Wu S, Ma C, Song S, Jin F, Niu Y, Tong WM. Front Oncol 10 611191 (2020)
  232. RNA m6A modification: Mapping methods, roles, and mechanisms in acute myeloid leukemia. Yin R, Li Y, Tian W, Zhou F, Zhang H. Blood Sci 4 116-124 (2022)
  233. RNA m6A-Regulated circ-ZNF609 Suppression Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating FTO. Yu P, Wang J, Xu GE, Zhao X, Cui X, Feng J, Sun J, Wang T, Spanos M, Lehmann HI, Li G, Xu J, Wang L, Xiao J. JACC Basic Transl Sci 8 677-698 (2023)
  234. Rational Design and Optimization of m6A-RNA Demethylase FTO Inhibitors as Anticancer Agents. Huff S, Kummetha IR, Zhang L, Wang L, Bray W, Yin J, Kelley V, Wang Y, Rana TM. J Med Chem 65 10920-10937 (2022)
  235. Recent Advances of RNA m6A Modifications in Cancer Immunoediting and Immunotherapy. Ma S, Barr T, Yu J. Cancer Treat Res 190 49-94 (2023)
  236. Recognition of G-quadruplex RNA by a crucial RNA methyltransferase component, METTL14. Yoshida A, Oyoshi T, Suda A, Futaki S, Imanishi M. Nucleic Acids Res 50 449-457 (2022)
  237. Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladder. Koch J, Neuberger M, Schmidt-Dengler M, Xu J, Carneiro VC, Ellinger J, Kriegmair MC, Nuhn P, Erben P, Michel MS, Helm M, Rodríguez-Paredes M, Nientiedt M, Lyko F. iScience 26 107300 (2023)
  238. Role of m6A RNA Methylation in Thyroid Cancer Cell Lines. Allegri L, Baldan F, Molteni E, Mio C, Damante G. Int J Mol Sci 23 11516 (2022)
  239. Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers. Tao Z, Zhao Y, Chen X. PeerJ 8 e9589 (2020)
  240. Sequence-specific m6A demethylation in RNA by FTO fused to RCas9. Rau K, Rösner L, Rentmeister A. RNA 25 1311-1323 (2019)
  241. Stage-specific requirement for METTL3-dependent m6A modification during dental pulp stem cell differentiation. Luo H, Liu W, Zhou Y, Zhang Y, Wu J, Wang R, Shao L. J Transl Med 20 605 (2022)
  242. Structural and functional characterization of TrmM in m6 A modification of bacterial tRNA. Jeong H, Lee Y, Kim J. Protein Sci 31 e4319 (2022)
  243. Structural basis for MTA1c-mediated DNA N6-adenine methylation. Chen J, Hu R, Chen Y, Lin X, Xiang W, Chen H, Yao C, Liu L. Nat Commun 13 3257 (2022)
  244. Structural insights into DNA N6-adenine methylation by the MTA1 complex. Yan J, Liu F, Guan Z, Yan X, Jin X, Wang Q, Wang Z, Yan J, Zhang D, Liu Z, Wu S, Yin P. Cell Discov 9 8 (2023)
  245. Structural insights into molecular mechanism for N6-adenosine methylation by MT-A70 family methyltransferase METTL4. Luo Q, Mo J, Chen H, Hu Z, Wang B, Wu J, Liang Z, Xie W, Du K, Peng M, Li Y, Li T, Zhang Y, Shi X, Shen WH, Shi Y, Dong A, Wang H, Ma J. Nat Commun 13 5636 (2022)
  246. Structure and regulation of ZCCHC4 in m6A-methylation of 28S rRNA. Ren W, Lu J, Huang M, Gao L, Li D, Wang GG, Song J. Nat Commun 10 5042 (2019)
  247. Structure of the Caenorhabditis elegans m6A methyltransferase METT10 that regulates SAM homeostasis. Ju J, Aoyama T, Yashiro Y, Yamashita S, Kuroyanagi H, Tomita K. Nucleic Acids Res 51 2434-2446 (2023)
  248. Systematic expression analysis of m6A RNA methyltransferases in clear cell renal cell carcinoma. Gundert L, Strick A, von Hagen F, Schmidt D, Klümper N, Tolkach Y, Toma M, Kristiansen G, Ritter M, Ellinger J. BJUI Compass 2 402-411 (2021)
  249. The Alteration of m6A Modification at the Transcriptome-Wide Level in Human Villi During Spontaneous Abortion in the First Trimester. She J, Tan K, Liu J, Cao S, Li Z, Peng Y, Xiao Z, Diao R, Wang L. Front Genet 13 861853 (2022)
  250. The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer. Ge Y, Zhang Y, Yang S, Liu T, Zhang T, Feng Y, Wang C, Liang G. J Oncol 2023 9822995 (2023)
  251. The N-terminal methyltransferase homologs NRMT1 and NRMT2 exhibit novel regulation of activity through heterotrimer formation. Faughn JD, Dean WL, Schaner Tooley CE. Protein Sci. 27 1585-1599 (2018)
  252. The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression. Liu N, Zhang J, Chen W, Ma W, Wu T. J Exp Clin Cancer Res 42 263 (2023)
  253. The characteristics of mRNA m6A methylomes in allopolyploid Brassica napus and its diploid progenitors. Li Z, Li M, Wu X, Wang J. Hortic Res 10 uhac230 (2023)
  254. The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers. Zhang Y, Ma Z, Li C, Wang C, Jiang W, Chang J, Han S, Lu Z, Shao Z, Wang Y, Wang H, Jiao C, Wang D, Wu X, Shen H, Wang X, Hu Z, Li X. Nat Commun 13 3061 (2022)
  255. The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. van Tran N, Ernst FGM, Hawley BR, Zorbas C, Ulryck N, Hackert P, Bohnsack KE, Bohnsack MT, Jaffrey SR, Graille M, Lafontaine DLJ. Nucleic Acids Res. 47 7719-7733 (2019)
  256. The interactome of a family of potential methyltransferases in HeLa cells. Ignatova VV, Jansen PWTC, Baltissen MP, Vermeulen M, Schneider R. Sci Rep 9 6584 (2019)
  257. The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia. Yang J, Li L, Cheng J, Lu J, Zhang S, Wang S, Zhao L, Zhou L. J Cancer Res Clin Oncol (2023)
  258. The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma. Zhu D, Liu Y, Chen J, Wang Q, Li Y, Zhu Y, Feng J, Jiang J. J Transl Med 20 298 (2022)
  259. The novel putative methyltransferase METTL7A as one prognostic biomarker potentially associated with immune infiltration in human renal cancer. Yang Z, Zhang W, Li L, Hu N, Dong X, Chen Y, Cai W, Yin L, Liu F, Tang D, Dai Y. Heliyon 9 e15371 (2023)
  260. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis. Liu T, Zhuang XX, Qin XJ, Wei LB, Gao JR. Inflamm Res 72 623-638 (2023)
  261. Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma. Liu Q, Qi J, Li W, Tian X, Zhang J, Liu F, Lu X, Zang H, Liu C, Ma C, Yu Y, Jiang S. Cancer Cell Int 23 298 (2023)
  262. USP1/UAF1-Stabilized METTL3 Promotes Reactive Astrogliosis and Improves Functional Recovery after Spinal Cord Injury through m6A Modification of YAP1 mRNA. Ge X, Ye W, Zhu Y, Cui M, Zhou J, Xiao C, Jiang D, Tang P, Wang J, Wang Z, Ji C, Zhou X, Cao X, Liu W, Cai W. J Neurosci 43 1456-1474 (2023)
  263. WTAP Function in Sertoli Cells Is Essential for Sustaining the Spermatogonial Stem Cell Niche. Jia GX, Lin Z, Yan RG, Wang GW, Zhang XN, Li C, Tong MH, Yang QE. Stem Cell Reports 15 968-982 (2020)
  264. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Chen Y, Peng C, Chen J, Chen D, Yang B, He B, Hu W, Zhang Y, Liu H, Dai L, Xie H, Zhou L, Wu J, Zheng S. Mol. Cancer 18 127 (2019)
  265. Letter WTAP-VIRMA counteracts dsDNA binding of the m6A writer METTL3-METTL14 complex and maintains N6-adenosine methylation activity. Yan X, Liu F, Yan J, Hou M, Sun M, Zhang D, Gong Z, Dong X, Tang C, Yin P. Cell Discov 9 100 (2023)
  266. YTHDC1 regulates distinct post-integration steps of HIV-1 replication and is important for viral infectivity. N'Da Konan S, Ségéral E, Bejjani F, Bendoumou M, Ait Said M, Gallois-Montbrun S, Emiliani S. Retrovirology 19 4 (2022)
  267. YTHDF2 Suppresses Notch Signaling through Post-transcriptional Regulation on Notch1. Lee B, Lee S, Shim J. Int J Biol Sci 17 3776-3785 (2021)
  268. m6A epitranscriptomic modification regulates neural progenitor-to-glial cell transition in the retina. Xin Y, He Q, Liang H, Zhang K, Guo J, Zhong Q, Chen D, Li J, Liu Y, Chen S. Elife 11 e79994 (2022)
  269. m6A epitranscriptomic regulation of tissue homeostasis during primate aging. Wu Z, Lu M, Liu D, Shi Y, Ren J, Wang S, Jing Y, Zhang S, Zhao Q, Li H, Yu Z, Liu Z, Bi S, Wei T, Yang YG, Xiao J, Belmonte JCI, Qu J, Zhang W, Ci W, Liu GH. Nat Aging (2023)
  270. m6A methyltransferase METTL3 promotes oral squamous cell carcinoma progression through enhancement of IGF2BP2-mediated SLC7A11 mRNA stability. Xu L, Li Q, Wang Y, Wang L, Guo Y, Yang R, Zhao N, Ge N, Wang Y, Guo C. Am J Cancer Res 11 5282-5298 (2021)


Quick links